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ABSTRACT 
Cytoch ro me c oxidase (ferrocytochrome c : 02 
oxidoreductase ; EC 1.9. 3.1) is the terminal enzyme in the 
mitochondrial electron transport chain, catalyzing the transfer of 
electrons from ferrocytochrome c to molecular oxygen. The 
effects of two large amphiphilic molecules - valinomycin and 
dibucaine upon the spectra of the isolated enzyme and upon the 
activity of both isolated enzyme and enzyme in membrane 
systems are investigated by using spectrophotometric and oxygen 
electrode techniques. 
The results show that both valinomycin and dibucaine 
change the Soret region of the speetrum and cause a partial 
inhibition in a concentration range higher than that in which they 
act as ionophores. It is concluded that both valinomycin and 
dibucaine binding induce a conformational change of the protein 
structure which modifies the spectrum of the a3 CUB centre and 
diminishes the rate of electron transfer between cytochrome a 
and the binuclear centre. 
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INTRODUCTION 
I. General features of cytochrome oxidase 
Cytochrome c oxidase (ferrocytochrome c: 02 
oxidoreductase; EC 1.9.3.1 )is the terminal enzyme of the electron 
transport chain located in the eukaryotic inner mitochondrial 
membrane and the plasma membrane of some prokaryotes. It 
catalyzes a four-electron reduction of oxygen to water and the 
oxidation of ferrocytochrome c . As the diagram in Fig.1 shows, 
electrons flow from cytochrome c bound at the external("C") face 
to an oxygen reduction site(Mitchell 1966a) and at the same 
time a proton electrochemical potential is generated across the 
membrane by a combination of the consumption of matrix protons 
during the reduction of oxygen and the translocation of protons 
from matrix to intermembrane spac@(Wikstr6m 1977, Chan and Li 
1990). The overall reaction can be described as follows : 
4 cytochrome c2+ + 4H+ + 021---~ 4 cytochrome 03+ + 2H20 
Eq. 1 
This proton electrochemical potential is composed of a pH .. 
gradient(alkaline inside) and a membrane potential (negative 
inside). and is utilized to drive the thermodynamically 
unfavourable synthesis of ATP , via the F1 Fo ATP synthetase. 
Cytochrome c oxidase can be purified from many sources, 
such as bacteria , yeast and mammals. Cytochrome oxidase from 
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Fig. 1. A model for cytochrome c oxidase function in 13 
membranes 
Adopted from Fig. 1 ( Cooper 1990). C and M sides are referring to 
cytosol side and mitochondrial matrix side respectively. The "+" 
side refers to positively charged side , which in this case is· the 
"c" side:·The "~"; side refers to negatively charged side, which in 
this case is the "M" side. 
mammals , especially that from bovine heart, has been most 14 
extensively studied. It contains 13 polypeptide subunits 
(Kadenbach et al1983) and has a molecular weight of 200,000 per 
monomer. It can also exist as a dimer(Wikstrom et al 1981). The 
three heaviest polypeptides , subunits I , II and III are coded by 
mitochondrial DNA . The smaller polypeptides are coded· by 
nuclear DNA. Chemical labelling , cross-linking and antibody 
binding have been used to probe subunit structure, orientation in 
the membrane and interrelationships . The results as reviewed by 
Cooper et al (1991) are summarized in the scheme of Fig. 2. 
Fig. 2 shows how subunits I and III are buried in the 
hydrophobic . membrane and subunit II "'binds c. All the subunits 
are transmembranous , except for subunit V which faces the 
matrix and subunits VI and VII which face the cytoplasm. 
The eukaryotic enzyme contains two iron-containing haem A 
groups and two functional copper atoms, CUA and CUB (Wikstrom 
et al 1981) The two haems are in very different 
environments(Keilin and Hartree 1939) : haem a is usually low 
spin and does not bind ligands while haem a3 is usually high spin 
and reacts with various ligands. The two copper atoms are 
integral parts of the electron transfer apparatus: CUA accepts 
electrons directly from cytochrome c (Hill 1990) and CUB forms 
part of the 02 reduction site with haem a3. The stoichiometry and 
function of a possible third copper atom "CuX" (Steffens et al 
1987) are uncertain. The roles of one zinc and one magnesium 
atom (Einarsdottir and Caughey 1984, 1985) have also not been 
determined, although Yewey and Caughey(1987) suggested that 
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Fig. 2. Membrane orientation of cytochrome c oxidase 1 5 
Adopted from Fig.1 ( Cooper et al 1991). Different patches 
represent different subunits and their relative positions when the 
enzyme is located in membrane. Subunits IX, X, XI, XII and XIII are 
omitted for clarity. 
the intrinsic magnesium might be essential for ATP binding. 16 
Direct localization of the prosthetic groups has been harder 
to achieve as the haems and coppers are labile under the 
dissociating conditions used to separate subunits via SDS PAGE or 
similar means. But several pieces of evidence indicate that 
subunits land .11 contain all four redox centers. Firstly , subunit II 
has an amino acid sequence homologous to that of copper 
proteins of the plastocyanin type in plant photosynthesis(Colman 
et al 1978}. So the binding site for CUA is presumably in subunit 
II. This leaves cytochrome a and the binuclear center on subunit I. 
Secondly, bacterial aa3-type cytochrome oxidases have a 
relatively simple subunit. composition . .;> In all the bacteria from 
which such an oxidase has been isolated I no more than four 
subunits have been found (Poole 1988) . The isolated Paracoccus 
oxidase has two subunits which resemble the two largest 
subunits in the mitochondrial oxidase in their hydrophobicity I 
immunological cross-reactivity(Ludwig 1982)and sequence 
homology(Steffens et al 1987) . This enzyme is identical or 
closely similar to the mitochondrial enzyme with respect to 
electron transfer activity and spectroscopic parameters(Albracht 
et al 1980). A third loosely associated subunit in the Paracoccus 
enzyme resembles subunit III of mammalian enzyme. 
Chemically modified cytochrome c derivatives bind 
covalently to subunit II(Bisson et al 1980). The haem c binding 
subunits of Thermus thermophilus (Buse et al 1989)and of 
PS3(Ishizuka et al 1990) are also partially homologous with 
eukaryotic subunit II. So apparently subunit 1/ contains a high 
affinity cytochrome c binding site Cytochrome c protects 1 7 
subunit II from labelling with water-soluble 
carbodiimides(Bisson and Montecucco 1982, Kadenbach and Stroh 
1984) However , there was also some protection of subunits VII, 
X, XI, and XIII This could indicate substrate-induced 
conformational chahge or that nuclear subunits play a facilitatory 
role in cytochrome c binding. 
Kinetic studies (Cooper 1990) reveal that the reaction does 
not obey conventional Michaelis-Menten kinetics at low ionic 
strength. Non-linear Lineweaver-Burk or Eadie-Hofstee plots are 
obtained which consist a 'high-affinity, low turnover' phase and a 
'low-affinity, high turnover 'phase . -';hat led to the suggestion 
that there was a second low affinity site for cytochrome c on 
cytochrome c oxidase. Erecinska(1977) suggested that subunits V 
and VI provide a· low affinity site. But as both the PS3 (Nicholls 
and Sone 1984)and Nitrobacter agi/is enzymes{Fukumori and 
Yamanaka 1984) possess a kinetically measurable low affinity 
site, it appears likely that nuclear -coded subunits are not 
essential parts of the binding site for a second cytochrome c 
molecule. The low affinity site may be comprised of phospholipid, 
perhaps involving cardiolipin(Trivedi et al 1986). 
Subunit III removal does not affect metal content or enzyme 
turnover(Yewey and Caughey 1987}. It also does not dramatically 
changeelectran . transport or the optical spectrum(Penttila et al 
1979, Saraste et al 1980) . Complete removal of subunit III by ex-
chymotrypsin treatment of the bovine enzyme(Wilson and 
Prochaska 1990), or cytochrome c affinity chromatography of rat 
liver enzyme in the presence of lauryl maltoside(Thompson et al 1 8 
1985} showed that the proton translocation was cut by 50%. The 
aa3-type cytochrome c oxidase from Paracoccus ,which was 
originally purified as a two subunit enzyme, had a proton 
translocation stoichiometry of 0.6 H+/e- (Poole 1988). DeCO, the 
carboxyl~specific protein modifying reagent which binds a 
glutamic acid residue in a part of the presumed proton 
translocation cha.nnel in ATP synthetase( Hoppe and Sebald 1984), 
also binds Glu-90, a conserved subunit II/ residue(Prochaska et al 
1981). It is far more effective in inhibiting proton translocation 
than electron transfer{Azzi et al 1984}. This evidence indicates 
that· subunit HI. is important in'" modulation of proton 
translocation It is also suggested by Haltia et al (1989) to be 
necessary for the correct assembly of subunit I and II. 
... . The functions -of the ·nuclearcoded subunits are less clearly 
understood. Bisson et al (1987) showed that millimolar 
concentrations of ATP abolish the high affinity Km and linearize 
the Eadie-Hofstee plots. But label/ing experiments with 
carbodiimides showed no ATP-induced change in cytochrome c 
binding to subunit II , the presumed high-affinity c binding site , 
and photo-affinity labelling showed that ATP binds to sites on 
subunits IV and VII. These results indicate that nuclear subunits 
may undergo conformational change upon binding ATP. 
Kadenbach(1986) suggests that allosteric effectors such as ATP 
can change the activity of cytochrome c oxidase by binding to 
specific sites on nuclear-coded subunits. 
II. Conformations of cytochrome oxidase 
In addition to fully oxidized ' resting' enzyme and fully 
reduced enzyme, cytochrome c oxidase can exist in transient 
forms , such as 'pulsed' enzyme .This is produced by pulsing 02 
into·fully reduced enzyme in the absence of ferrocytochrome c. 
Brunori et al (1979) demonstrated that the 'pulsed' oxidase 
accepts four electrons in the conversion to the fully reduced 
form, and the lag in intramolecular electron transfer is partially 
or fully relieved. The spectral consequence of pulsing the enzyme 
is a red shift of the Soret peak. Pulsed enzyme shows a spectral 
and kinetic resemblance to. anot1:ter transient form, the 
'oxygenated' species(Wikstrom et al 1981). When pulsing the 
enzyme , a major part of the initial product can be the 'peroxy' 
form which may contain bound oxygen and two more electrons 
than the fully-oxidized from. This form then decays to the later 
'pulsed' form. (Moody et al 1991). 
The cause of the spectral differences between the resting 
and pulsed oxidase is unclear. SOS-PAGE electrophoresis does not 
show significant difference in subunit composition between the 
two species(Crinson 1991). The spectral difference must result 
from changes in tertiary structure in the vicinity of the redox 
centers. The similarity of the spectra of cyanocytochrome 
oxidase and the initial pulsed form led to the proposal that the 
initial pulsed ('peroxy') enzyme has a low-spin cytochrome 
a3(Wrigglesworth at al 1988). The late-pulsed form may 
represent an intermediate cytochrome a 3 species in the 
19 
relaxation of the initial pulsed enzyme to the resting state. 20 
Raman spectroscopy(Babcock et al 1981 )has revealed a low spin 
ferric haem a3, but MCD data suggested a high spin state(Babcock 
et al 1976). This discrepancy may be due to the heterogeneity of 
the initial pulsed enzyme, evidenced by the decay in minutes 
. from· the initial 'peroxy' form to.· the late form which is stable for 
several hours. Even the latter form is not homogeneous. Moody et 
al (1991) claimed that in their 'fast' enzyme preparation, there 
are at least two subpopulations, while Crinson(1991) also 
reported that the relationship between the cytochrome a 
reduction and the enzyme turnover is biphasic, indicating the 
existence· ofa low-turnover and a ~igh-turnover forms of the 
enzyme. Pulsing the enzyme increases the proportion in the high-
turnover form. A sulphur atom from a nearby amino acid , a 
. partially reduced oxygen atom,anda water molecule may be the 
bridging ligands between haem a3 and CUB in the resting, initial 
pulsed{'peroxy'), and late-pulsed enzymes respectively(Crinson 
1991). 
It has been generally accepted that the ,oxidized (,resting') 
enzyme contains two magnetically isolated spin 8=112 centers, 
which correspond to the low spin ferric haem a and cupric CUA 
respectively(Wikstrom et al 1981). It also contains a spin-
coupled 8=2 centre, which can be best interpreted as arising from 
high-spin ferric haem a3 (8=5/2) antiferromagnetically coupled 
to cupric CUB (8=1/2), yielding a binuclear center of spin 
8=2(Tweedle et al 1978). 
III. Ligands of cytochrome oxidase 
Cytochrome a is a hexacoordinated haem in which both 
axial positions are occupied by histidines, so it does not react 
with exogenous ligands. On the other hand , cytochrome a3 is a 
. . pentacoordinated haem' with only one histidine as its axial .Iigand, 
so it can react with various exogenous ligands(Saraste 1990). 
Oxidized enzyme in the 'resting' state as isolated is 
conspicuously unreactive with cyanide, which reacts readily 
with cytochrome a3 under turnover conditions or in partially 
reduced enzyme(Nicholls and Chance 1974, Erecinska and Wilson 
~·97a) .. Th'at has led to the suggestion .that the sixth axial position 
of haem a3 in resting enzyme is occupied by a endogenous ligand, 
such as a J.L-oxo bridge(Reed and Landrum 1979), or a sulfur atom 
from a nearby amino' ·acid(Crinson1991}. Reductants will break 
this ligation and thus lead to higher reactivity with exogenous 
ligands including cyanide . 
The fact that haem a3 but not haem a binds ligands in both 
the ferrous and ferric forms has been extensively used to 
evaluate the individual spectra of the two haems(Wikstrom et aJ 
1981). Among these ligands , cyanide is the most studied species. 
Cyanide is a very effective inhibitor of cytochrome c oxidase. A 
stoichiometric amount of cyanide is sufficient to inhibit the 
> enzyme • completely(Nicholls and Hildebrandt 1978a). Initially 
Nicholls and Hildebrandt (1978b) concluded that the binding of a 
single HCN molecule prevented the reduction of both a3 and CUB. 
But later this conclusion was revised(Nicholls and Chanady 1982}. 
21 
Excess reductant permits the introduction of three reducing 22 
equivalents into the cyanocytochrome aa3, i.e. cytochrome a, CUA 
and CUB can all be reduced in the presence of cyanide. 
MCD spectroscopy (Babcock et al 1976) reveals a low spin 
ferricytochrome a3 -HCN complex , but no low spin. EPR signal 
'.: :oor.responding . to this complex is generated in the 'resting' 
enzyme. However , a low spin cyanide complex signal is detected 
in the presence of reducing equivalents(Shaw et al 1978). 
This is explained by magnetic susceptibility 
studies(Tweedle et al 1978). When cyanide is added to the 
oxidized enzyme, a binuclear complex , presumably ferric haem 
a3-HCN(S=1/2)-cupric CUB (8=1/2), is formed , with . qOLJPling 
between low spin-iron and copper. EPR cannot detect this 
complex, but MCD can still detect it. 
The cyanide induced high' to:low spin change can also be 
monitored· spectrophotometrically(Nicholls et al 1976), as 
evidenced by a red shift of the Soret peak upon adding cyanide. 
The binding of cyanide with oxidized enzyme is very slow, but the 
values of the rate constants vary considerably. 
The problem of heterogeneity in the isolated enzyme has 
long been a source of discussion(Hartzell et al 1988}. Moody et al 
(1991) claimed that in their enzyme preparation , there is a 'slow' 
subpopulation in which the haem a3 is in the high spin form, and 
two 'fast' subpopulations in which some haem a3 is in the low 
spin form. The pH used in the preparation has quite a significant 
influence. Moody et al(1991) argued that the 'fast' and 'slow' 
forms of oxidase are equivalent to the late 'pulsed' and 'resting' 
forms of oxidase. If this is correct, the rate constants obtained 23 
by Van Buuren et al (1972), Brittain and Greenwood(1976) and 
Jones et al (1984) were characteristic of mixed species of the 
enzyme. Since these authors did not discuss in detail the problem 
of heterogeneity and the contributions of 'fast' form to their 
'resting' preparations, and 'peroxy' form to their 'oxygenated' or 
'pulsed' preparations, Mitchell et al (1992) may be correct in 
suggesting that the earlier enzyme preparations were mixtures of 
the 'slow'(resting), the 'fast'('pulsed') and the 'peroxy' forms. 
Nicholls et al (1976) showed that although the rate of 
cyanide binding to fully reduced enzyme was more rapid than to 
fully - o~idized.species •. the rate of .;Onset of inhibition under 
turnover conditions was at least an order of magnitude. greater 
still. Jones et al(1984) proposed that a transient 2 or 3-electron-
. reduced fOrm of the enzyme during·. turnover was responsible for 
the observed extremely rapid binding. Mitchell et al (1992) 
examined the rates of binding to the fully oxidized(O), two-
electron-reduced peroxy(P) and the three-electron-reduced oxy-
ferryl(F) forms of the enzyme, and concluded that none of these 
states is responsible for the extremely rapid cyanide binding 
during turnover. On the other hand, they detected a very small 
fraction of one-electron-reduced (E state) oxidase within the 
'fast' oxidized enzyme they prepared according to the method of 
Moody et al (1991) . This small 'E' fraction has a rate constant for 
cyanide binding in excess of 104 M- 1s-1. It is concluded by 
these authors to be the species responsible for the rapid binding 
of cyanide during turnover. The Estate , according to them, is not 
oxidizable by oxygen, but can be slowly oxidized by ferricyanide. 24 
The difference spectrum following incubation with ferricyanide 
suggested that the electron in the E state is free to equilibrate 
between the redox centers. 
The binding of ferricytochrome c (or poly-L-Iysine) was 
,. reported to' induce a global protein conformational change that 
increases the HeN binding rate(Musatov and Konstantinov 1988). 
But Mitchell et al (1992) found that the cytochrome c 
stimulation of cyanide binding is most significant at 
intermediate ionic strengths, though the binding of cytochrome c 
to cytochrome oxidase is known to be electrostatic in nature. So 
the latter propose that the mediation.:ll of electron transfer from 
one-electron-reduced , cyanide-liganded enzyme to the free 
, 
ferric oxidase by cytochrome c or poly-L-Iysine, rather than a 
··global protein conformational change , is responsible for the 
stimulation. 
The final word has not been said yet as to which species is 
responsible for the extremely rapid inhibition by cyanide during 
turnover. Dioxygen activation and reduction in cytochrome c 
oxidase is a complicated process which can involve as many as 11 
transient states of the enzyme(Babcock and Wikstrom 1992). 
Intracentre electron transfer means that several species can 
share the same redox status. Even if we suppose all the species 
that have been tested are truly involved in this, oxidoreduction 
cycle, there are still too many species left untested. Some 
transient species might be so thermodynamically unstable that 
their lifetime is very short, making them difficult to study. For 
example, Shaw et al{1978} detected by EPR a high spin ferric 25 
haem 83 which is highly reactive with ligands such sulphide, 
cyanide and azide when generated by anaerobic oxidation of the 
reduced enzyme with ferricyanide or porphyrexide. The lifetime 
of this form is no longer than a few seconds. 
: _.' - I conclude that the hi.gher reactivity with ligands of the 
enzyme in turnover conditions does not imply that either the 
'pulsed' or the 'oxygenated' form is of catalytic significance. 
Azide reacts comparatively quickly with the oxidized 
enzyme in contrast to cyanide(Nicholls and Chance 1974). But its 
spectral effect upon the enzyme is complex{Nicholls et al 1976). 
-At a low ·concentration· « 1 mM),·· the sf)ectrum shows a slight blue 
shift. At higher levels (> 20mM), the Soret peak is. shifted 
towards the red. Since azide is the one ligand which gives rise to 
both ::high,;;and" low-spin complexes with other haem 
proteins{Nicholls 1976), it might be that at low concentration , 
azide causes a low to high spin shift of haem 83 , while at high 
concentration , it has the opposite effect. Neither effect is as 
marked as those produced by cyanide and forn:ate(formate shifts 
the Soret peak to the blue (Nicholls 1976)), and in neither case is 
any EPR-detectable low spin or high-spin haem species formed 
(Wilson and Leigh 1972). In partially reduced states of the 
enzyme , EPR identifies a signal indicative of a low spin ferric 
haem 8S to which azide is bound. Failure to detect an EPR signal 
in the 'resting' enzyme-azide complex may be due to a similar 
cause to that with cy'anide. A ferric 8s-azide(S=1/2)- cupric 
CUB(S=1/2) species may be formed with weak ferromagnetic or 
.. 
antiferromagnetic coupling between low-spin iron and copper. 26 
Nicholls and Hildebrandt(1978a) pointed out that while the 
reduction of cytochrome a in the presence of azide under aerobic 
steady state conditions is almost instantaneous, the high to low 
spin shift of cytochrome a3 , which is characterized by a red 
shift of the high spin ferric peak in the Soret region, is relatively 
slow. This transition correlates with a 605nm(ferrous) a peak 
shift towards the blue of a few nanometers during the steady 
state. The a peak of fully reduced enzyme in the presence of azide 
remains at 605nm. The a peak shift does not occur with cyanide, 
even though , like azide , it gives a low spin(red-shifted) Soret 
peak. After studying similar effects caused by sulphide and alkyl 
sulphides, Nicholls and Hildebrandt(1978a) concluded that the a 
peak shift requires both (i) a low-spin cytochrome a 3 (ii) a 
somewhat lipophilic ligand to haem a3. This phenomenon is an 
important indication of the presencE\, of haem I haem interaction 
in the enzyme. 
Sulphide reacts readily with oxidized cytochrome oxidase , 
yielding an optical change similar to that induced by cyanide 
(Nicholls et al 1976), indicative a high to low spin transition of 
ferric a3, but the red shift of the Soret peak is more marked with 
increased absorption at 44Snm . A signal typical of low spin 
ferric haem-sulphide compounds is detected by EPR in the 
oxidized enzyme-sulphide complex(Wilson et al 1976). 
Some phenomena , such as the high reactivity with oxidized 
enzyme , the increase of absorption at 44Snm, and the detection 
of low spin EPR signals in the absence of other reducing agents, 
can be readily explained by the partial reduction of the enzyme 27 
by sulphide. 
Formate induces a blue shift of the Soret peak(Nicholls 
1976), indicating a high spin ferric haem as-formate complex. 
This was confirmed by an EPR study(8abcock et al 1976). In 
" 'contrast ·lo resting enzyme , cyanide- liganded or azide-liganded 
enzyme, formate apparently keeps haem as in a high spin state 
whether haem a is reduced or not{ Nicholls 1976}. Competitive 
binding was found between the formate and azide pair (Nicholls 
1975), and the formate and cyanide pair (Nicholls 1976). 
Moody et al (1991) report that incubation of their 'fast' 
oxidase with formate produces a form of the enzyme with 
spectral and kinetic properties almost identical to those of 
'slow' oxidase .These include the Soret peak position, the slow 
binding with cyanide· and the lag in intramolecular electron 
transfer. These authors suggested that formate may mimic a 
binuclear center ligand which is present in the 'slow' form of 
cytochrome oxidase. Schoonover and Palmer(1991) also reported 
that the 'g=12' signal , which is characteristic of high-spin haem 
a3 in 'slow' oxidase, reappears after adding formate to 'fast' 
oxidase. Although formate gives no spectroscopic sign of haem-
haem interaction , like cyanide it does show kinetic evidence of 
such interactions(Nicholls 1976}. tts affinity for the ferric high-
spin as declines as haem a becomes more reduced, while the 
affinity of cyanide for the ferric low-spin a S increases as haem 
a becomes more reduced. So the redox state of haem a can 
influence the affinity of formate and cyanide for ferric haem a3. 
IV. lonophores 
lonophores are lipid-soluble molecules that greatly 
decrease the electrical resistance of lipid bilayer membrane 
(Cramer and Knaff 1991). They can be classified as (i) mobile 
carriers such as nigericin, FCCP and valinomycin whose activity 
is frozen out at temperatures below the membrane lipid phase 
transition due to their mobile nature (ii) channels such as 
gramicidin whose activity is relatively insensitive to 
temperature in membranes with a phase transition. 
Valinomycin (see Fig. 3 for its molecular structure) is one 
of a group of antibiotics produced by Streptomyces . It contains 
three repeating units of (L-Iactate)-(L-valine)-(D-
hydroxyisovalerate)-(D-valine). The dehydrated K+ ion is 
coordinated precisely and specifically (the cation specificity is 
Rb+>K+»Na+>U+) to carbonyl groups in the hydrophilic interior of 
the macrocycle, whose exterior is nonpolar and thereby soluble in 
the membrane bilayer. Because of its K+ carrying ability , 
valinomycin dissipates the membrane potential ~'" in the 
presence of K+. It has been extensively used in mitochondrial and 
reconstituted systems to investigate the effect of a membrane 
potential ~'" upon the activity of the respiratory chain. 
Mitchell(1966b) proposed that cytochrome oxidase 
generates a electrochemical proton gradient Ll~H+ by catalysing 
28 
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Fig. 3. (a) Structural formula of valinomycin 29 
Adopted from Fig. 3.328 ( Cramer and Knaff 1991). 
(b) conformational change of valinomycin upon 
binding of potassium ion 
The six carbonyl oxygen atoms in valinomycin are in one plane 
,when valinomycin is dispersed in polar solvents(Ovchinnikov 
1974) in the absence of K+. In the presence of K+, the six carbonyl 
oxygen atoms coordinate with a K+ and undergo conformational 
change, resulting a octahedral shape. 
e- transfer from ferrous cytochrome c on the C side of the 30 
membrane and H+ transfer from the M side to the haem a3/CuB 
center, where electrons and protons were consumed in the 
reduction of dioxygen to water. This is thermodynamically 
equivalent to translocation of one H+ from the M side to the C 
side per transferred e- ,even though no H+ ions are released on 
the latter side(Wikstrom et al 1981). 
Later it was found that cytochrome c oxidase catalyses 
true H+ translocation with uptake of 2H+ / e- on the M side , 
release of 1 H+/e- on the C side of the membrane and consumption 
of 1 H+ in the reduction of 02 (Wikstrom 1977, Proteau et al 
1983). The H+ pumping activity , i.e;: the acidification of the 
medium after a ferrous cytochrome c pulse, cannot be seen in the 
absence of valinomycin. The reason seems to be that as a K+ 
carrier, valinomycin markedly increases the K+ permeability over 
the H+ permeability to the membrane. But recently Steverding 
and Kadenbach(1989) reported that valinomycin not only acts as 
a ionophore, but also binds cytochrome oxidase tightly with a 
stoichiometry of 1 :1. This binding has both spectral and kinetic 
consequences. The difference spectrum shows that valinomycin 
induces a red shift of the Soret peak of the oxidized enzyme,an 
effect which is superficially similar to that achieved by adding 
cyanide to the enzyme or pulsing the enzyme. The same spectral 
change was also observed using isolated cytochrome oxidase 
from Paracoccus denitrificans, which contains only subunits 
and II( a third subunit was probably lost during purification). 
Since subunits I and II from Paracoccus denitrificans are 
analogous to subunits I and II from beef heart enzyme, the 3 1 
authors suggested that valinomycin binds to one of the two 
catalytic subunits of cytochrome oxidase. 
Steverding and Kadenbach(1989) also found that the 
stoichiometry of H+ pumped le- transferred reached a maximum 
in· oytochrome oxidase vesicles when the stoichiometry of 
valinomycin : cytochrome oxidase reached 1 . In the absence of 
valinomycin, only an alkalinization of the medium was observed, 
due to rapid proton uptake. They concluded that the translocation 
of K+ ions occurs via the enzyme-bound ionophore. It was also 
suggested that the H+ pumping activity of the enzyme might 
result from a change of catalytic properties of the reconstituted 
cytochrome oxidase after binding of valinomycin. 
This view was later supported by a comparative study of 
valinomycin and nonactin(Steverding and Kadenbach 1990). 
Nonactin, another K+ carrying jonophore , stimulated the passive 
influx of H+ into the vesicles which didnot contain cytochrome 
oxidase· at a greater rate than valinomycin did when Hel was 
added to the medium containing vesicles I suggesting that it 
might be a more powerful K+ carrier than valinomycin. The 
spectral shift and stimulation of the respiration rate of the 
reconstituted cytochrome oxidase induced by nonactin were 
nevertheless lower than those induced by valinomycin. This 
apparent contradiction was also explained by assuming that 
besides being a K+ carrier, valinomycin binds the enzyme directly 
and modifies its catalytic activity. 
Another comparative study was done using valinomycin and 
the channel-forming ionophore gramicidin(Prochaska and Wilson 32 
1991). At low concentrations, gramicidin achieved an almost 
identical H+ le- stoichiometry to that of valinomycin when 
ferrous cytochrome c was added to oxidase-containing 
proteoliposomes; at a high concentration, however, only an 
alkalinization was observed. Since the ion selectivity of 
gramicidin channels is H+>K+ (Cramer and Knaff 1991) there is 
some doubt as to which ion was translocated to dissipate the fl'JI 
during these experiments. But Prochaska and Wilson (1991) 
argued that as there are 106 more K+ ions than protons, K+ 
ions were dissipating the fl'JI at low gramicidin concentrations 
while at higher concentrations , H+ ion9 were also translocated . 
Since no spectral shift was found with gramicidin even at a 
high concentration, and the concentration required to stimulate 
proton translocation· is 40-70 fold less than with valinomycin, 
Prochaska and Wilson (1991) suggested that gramicidin does not 
bind the enzyme , or at least not in the same fashion. As it 
achieves an almost equal H+ le- ratio to that induced by 
valinomycin, this suggests that cytochrome oxidase is truly a 
redox-associated proton pump with the previously determined 
H+le- ratio of one. 
A similar valinomycin-induced red shift in the oxidized 
difference spectrum is also observed in phospholipid vesicles 
containing subunit III-deficient cytochrome oxidase(Prochaska 
and Wilson 1991), further supporting the idea that valinomycin 
binds with either subunit I or II as suggested by Steverding and 
Kadenbach(1989). 
v. local anesthetics 
Local anesthetics such as lidocaine, tetracaine and 
dibucaine are used for anesthesia as well as in the treatment of 
cardiac arrhythmias(MacDonald and Wann 1978). They depress 
'nerve action and cardiac signal conduction probably by blocking 
ion (Na+, K+ and Ca2+) channels in the membrane. Their effects 
are not limited to nerves, since they also affect a variety of 
other systems, including the respiratory chain in mitochondria 
(Chazotte and Vanderkooi 1981). Among these anesthetics , 
dibucaine is one of the most potent, whether in depressing nerve 
actions(Singer 1980) or inhibiting the.il respiratory chain(Chazotte 
and Vanderkooi 1981). 
Altogether, four different kinds of local anesthetic effects 
have been suggested in the literature: 
(1) interaction with lipid bilayers (Eftink et al 1985); 
(2) interaction with lipid molecules intimately associated with 
the protein (Chazotte and Vanderkooi 1981); 
(3) direct interaction with the protein without mediation of lipid 
(Chazotte et al 1982); 
(4) action as an uncoupler(Grouselle et al 1990). 
Chazotte and Vanderkooi (1981) found that local 
anesthetics inhibit all segments of the respiratory chain in 
mitochondria, with NADH dehydrogenase(Complex I) being the 
most sensitive , and cytochrome c oxidase (Complex IV) the 
least sensitive region. They also found that the 50% inhibitory 
33 
concentrations are inversely proportional to water solubility, 34 
suggesting that hydrophobic interactions may be of importance in 
determining the strength of ·interaction of the various agents 
with the enzyme . Concentrations of agents required for 
inhibition are too low to cause a general perturbation of the lipid 
··bilayer, and inhibition by different anesthetics occurs in 
different concentration ranges. This implies a degree of 
specificity which cannot be accounted for in terms of lipid 
bilayer perturbation. These authors concluded that local 
anesthetics either interact directly with the protein or with the 
lipid molecules intimately associated with the protein. It was 
also found that the inhibitory potency increases with the 
temperature. 
The dibucaine - cytochrome c oxidase interaction was also 
. studied by thermal . anafysis(Vanderkooi and Chazotte 1982). It 
was found that inhibition by dibucaine increases with increase 
of temperature. The authors suggested that dibucaine inhibits the 
enzyme activity by' causing a reversible perturbation of protein 
conformation whose magnitude is much smaller than that which 
accompanies thermal denaturation. 
Apart from the inhibitory effect" local anesthetics have 
also been reported to uncouple oxidative phosphorylation in 
isolated mitochondria (Oabadie et al 1987). Using a fluorescent 
dye, Grouselle et al (1990) demonstrated that local anesthetics , 
such as dibucaine, can reach mitochondria when applied to a cell 
culture medium . This process depends on their lipid-solubility 
and can be enhanced by the presence of a lipophilic anion such as 
T P B -. Local anesthetics have the same effects on mitochondria 35 
inside the cells as on isolated mitochondria, i. e. they can 
decrease, and probably even collapse, the mitochondrial 
transmembrane potential. These effects of local anesthetics are 
reversible. 
Singer(1980) studied the effects of four cationic local 
anesthetics on isolated cytochrome c oxidase. He found that 
benzocaine, the one uncharged anesthetic, had no detectable 
effect on enzyme function I while other three species cause a 
mixed type of inhibition, with the relative order of potency being 
dibucaine>tetracaine>procaine. He suggested an electrostatic 
interaction • but also pointed out thaF:' since procaine, dibucaine 
and tetracaine have similar pK values, inhibitory potency cannot 
be explained by such an electrostatic interaction alone. 
Noticing that the inhibitory constants (Ki values) are very 
similar to the anesthetic concentrations required to double the 
width of the endothermic transition of 
dipalmitoylphosphatidylcholine liposomes, Singer(1980) 
proposed that both electrostatic and hydrophobic interactions 
occur, with the charged portion of the anesthetic molecule 
competing with the cytochrome c for binding while hydrophobic 
interactions between the anesthetic and oxidase-associated 
phospholipids form non-productive substrate-enzyme complexes. 
Singer(1982) found that at pH 7.4 dibucaine behaved as an 
uncompetitive inhibitor of the isolated enzyme, while at pH 6.0 
the inhibition pattern became mixed in type. Positively charged 
dibucaine may act predominantly by competing with cytochrome c 36 
while the uncharged species interacts with the oxidase boundary 
lipid to form a non-productive complex. 
The effect of dibucaine on cytochrome oxidase 
proteoliposomes was similar to that with isolated enzyme, but 
less marked. This ' protective' influence of the bulk bilayer might 
represent a dilution effect, i.e. binding of some of the local 
anesthetic by the bilayers. 
In a follow up study , Singer(1983) showed that local 
anesthetics such as dibucaine and tetracaine had a much greater 
inhibitory effect on the stimulated (ionophore-treated)than on 
the unstimulated proteoliposome enzyme. The inhibition pattern 
of stimulated oxidase proteoliposomes is non-competitive with 
respect to cytochrome c co ncentration. P retreati ng 
proteoliposomes with local anesthetics completely prevented the 
stimulating effects of ionophores,such as valinomycin+FCCP. 
Singer(1983) suggested that this was due to the interaction 
between local anesthetics and the phospholipid component of the 
enzyme, which results in reduced internal electron transfer and 
dissociation of the oxidase from the regulatory role of the pH 
gradient. 
Casanovas et al (1983) investigated the effects of eight 
species of local anesthetics on isolated cytochrome c oxidase. 
The inhibition varied from competitive through mixed to a non-
competitive type. The patterns depended on anesthetic 
concentrations. These authors concluded that reagents presenting 
a strong anesthetic activity and existing in an ionized state bind 
electrostatically to the enzyme at the cytochrome c binding 37 
site, or to a site nearby . They also observed a linear correlation 
between enzyme affinity and the octanol-water partition 
coefficient of the anesthetics. So hydrophobic interactions are 
also involved • and the interaction between enzyme and weakly 
ionized molecules may be mainly hydrophobic in nature. These 
conclusions are however weakened by the existence of quite a 
few exceptions. 
A different model was offered by the same group(Casanovas 
et al 1985)in a study using the same local anesthetics . Here it 
was proposed that the binding site of local anesthetics is the 
phospholipids attached to cytochrome c oxidase. Strongly 
ionized molecules can bind to a peripheral site of the lipid phase 
surrounding the protein and therefore modulate the enzyme 
activity, resulting in mixed or non-competitive type of 
inhibition. This inhibition is relatively weak and may be 
electrostatic in nature. Weakly ionized and lipophilic molecules 
can compete with cytochrome c for binding at the active site 
located closer to the lipid hydrophobic phase. This inhibition is 
relatively strong and may involve both electrostatic and 
hydrophobic interactions. 
Stringer and Harmon(1990)· found that upon adding the 
artificial electron donors ascorbate and TMPD to intact 
mitochondria in the presence of dibucaine , the 604nm peak was 
nearly fully formed, but the 445nm peak only developed half of 
the height of that in the absence of dibucaine. Since 80-90% of 
the absorbance of reduced oxidase at 604nm is due to ferrous 
cytochrome a, and the rest to a3, while both cytochromes absorb 38 
equally at 445nm (Yonetani 1960), it was concluded that 
dibucaine inhibited electron transfer between the two 
cytochromes, allowing reduction of cytochrome a but not of a3 . 
The midpotentials of cytochromes c, a and a3 are not affected 
by dibucaine. Dibucaine does not alter the absorbance maxima of 
cytochrome a and a3.. On the other hand, the. reduction of CUA 
was hampered by dibucaine. So Stringer and Harmon (1990) 
propose that the attacking site of dibucaine was located neither 
on cytochrome a nor on cytochrome 83, but on CUA. 
Neither valinomycin nor dibucaine is a conventional oxidase 
ligand. Both are large molecules with multiple effects and no 
exact binding sites have been determined. In this thesis, the 
following questions are addressed: (i) what is the relationship 
between the dual role of valinomycin as enzyme ligand and as 
ionophore? (ii) do the results obtained by Steverding and 
Kadenbach (1990) demonstrate a relation between ligand binding 
and charge separation in the oxidase? (iii) what are the 
relationships between the roles of dibucaine as enzyme inhibitor 
and as membrane-perturbing agent? and (iv) do the results of 
Stringer and Harmon (1990) demonstrate a unique relation 
between dibucaine binding and electron transfer in the oxidase? 
The work described uses oxygen electrode, spectrophotometric, 
and fluorimetric techniques to study effects of valinomycin and 
dibucaine upon the enzyme in order to understand better the 
relationships between their roles as protein ligands and enzyme 
inhibitors and as membrane perturbants and ionophores. 
MATERIALS AND METHODS 
LIST OF REAGENTS: 
Reagent 
Acetic acid (1 N solution) 
Ammonium> sulphate 
Antimycin A(from Streptomyces kitazawaensis, 
crystalline) 
Ascorbate (L-ascorbic acid, sodium salt) 
Asolectin (Type IV-S, phosphatidylcholine) 
Catalase (EC 1.11.1.6) from Bovine liver 
.... Cholate (Cholic acid, sodium salt ) .. 
Cytochrome c (Horse heart I Type VI) 
Dibucaine hydrochloride 
Supplier 
Fisher Scientific 
BDH 
EDTA (Ethylenediamine tetraacetio· acid, disodium salt) 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
FCCP(p -trifluoromethoxycarbonylcyanide 
phenylhydrazone) Dr .P .Heytler 
(Dupont Chern.) 
D-Glucose BDH 
Glucose oxidase(EC 1.1.3.4. )from Aspergillus niger Type X Sigma 
HEPES(4-(2-hydroxyethyl)piperazineethanesulphonic 
acid) 
Hydrochloric acid 
Lauryl (n-dodecyl-b-D) maltoside 
Nigericin 
Potassium cyanide 
Potassium dihydrogen orthophosphate 
Res.Organ. 
Fisher Scientific 
Sigma 
Calbiochem. 
BDH 
BDH 
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Potassium ferricyanide 
di-Potassium hydrogen orthophosphate 
Potassium hydroxide(1 N solution) 
Potassium sulphate 
Sephadex G-2S(Bead size SO-1S0jlM) 
Sodium borate 
Sodium dithionite 
Sodium formate 
Sodium hydroxide 
Sodium nitrite 
Sodium phosphate .Monobasic 
Sodium phosphate. Dibasic 
Succinic acid (disodium salt) 
TMPO(N,N,N,' N,'-tetramethyl-p-phenylenediamine. 
Oihydrochloride salt) 
Tween-SO 
Valinomycin 
Fisher Scientific 
SOH 
Fisher Scientific 
SOH 
Sigma 
J.T.Baker 
SOH 
SOH 
Fisher Scientific 
BOH 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
Sigma 
* All reagents were of Analar™ grade or equivalent. 
Purification of beef heart cytochrome c oxidase and 
subm itochondrial particles 
The enzyme preparation used throughout these studies was 
beef heart mitochondrial cytochrome c oxidase .. The enzyme was 
purified according to the method of Kuboyama et al (1972). After 
connective and fat tissue has been removed , the beef heart is 
thoroughly minced and then washed several times in S mM sodium 
40 
phosphate, pH 7.4 . Submitochondrial particles are prepared from 41 
the washed mince according to the method described by Brodie 
and Nicholls (1970). The enzyme was isolated from these 
particles by differential detergent solubilization, initially in 
cholate and finally in Tween-SO, and repeated ammonium sulphate 
fractionation. Tween-SO was used instead of the Emasol used by 
Kuboyama et al(1972) . The final enzyme preparation was stored 
in 100mM sodium phosphate, pH7.4 , 0.2S% Tween-SO at -70oe. 
The haem a Iprotein ratio of submitochondrial particles is 
1.1 J.lmoles haem a Igram of protein. The haem a Iprotein ratios 
of the purified enzyme preparations used were S.S-9.0 J.lmoles 
haem a 19ram· of protein. The coocentration of protein was 
determined using the Biuret method (Gornall et al 1949). The 
concentration of cytochrome oxidase(two haems: a and a3 )was 
determined' using an extinction coefficient of 27mM-1 cm-1 fo r 
reduced minus oxidized enzyme at 60S-630nm(Nicholis 1975) 
The concentration of the stock purified enzyme was 
between 400 and 700 J.lM. The maximal turnover numbers were 
470-SS0 J.lM e-JlMaa3 -1 sec-1 in SOmM potassium phosphate, pH 
7.4 at 30oe. 
Preparation of pulsed cytochrome oxidase. 
Pulsed cytochrome oxidase was prepared according to the 
method described by Crinson and Nicholls (1992). Pulsed 
cytochrome oxidase is 'resting' oxidase which has been fully 
reduced and then exposed to oxygen. Sephadex G-2S beads were 
swollen by overnight stirring in excess SOmM potassium 
phosphate, pH 7.4 (30ml I g Sephadex G-25). The swollen beads 42 
were then poured into a glass column to form a 10cm x 1.5cm 
Sephadex G-25 gel filtration column. Purified oxidase in 50mM 
potassium phosphate , pH 7.4, 0.015% lauryl maltoside was 
reduced by the addition of 1.0mg/ml sodium dithionite and left on 
ice for 30 min to ensure complete reduction of the oxidase. 
Catalase (2000units/ml; one enzyme unit will decompose 1 Jlmole 
H202 per min at pH 7.0 at 25°C) was added to the mixture to 
ensure that any hydrogen peroxide was rapidly removed . The fully 
reduced enzyme was then loaded onto the column, which had been 
equilibrated with 50mM potassium phosphate , pH 7.4, 0.015% 
lauryl maltoside. This same air-saturated buffer medium was 
used to wash the enzyme through the column , the eluted enzyme 
being in the pulsed form as determined spectroscopically. The 
initial product has a Soret peak at 426nm and is unstable, as 
evidenced by the gradual blue shift of the Soret peak to 422nm, 
but this 422nm species is stable for at least 3 hours. 
Preparation of cyanide-liganded and formate-liganded 
cytochrome oxidase . 
Cyanide-liganded and formate-liganded cytochrome oxidase 
were formed by incubating 0.12 mM oxidase with 40 mM HCOONa 
or 2mM KCN respectively in 50 mM potassium phosphate , pH 7.4 
containing 0.015% lauryl maltoside. The mixtures were incubated 
at 4°C for 48 hours and then diluted to the desired concentrations 
in 50 mM potassium phosphate, pH 7.4 , 0.015% lauryl maltoside 
for use in the assays. 
Preparation of vesicles containing cytochrome oxidase 43 
Sonicated vesicles containing cytochrome oxidase were 
prepared according to the method of Proteau et al (1983). 250 mg 
L-a-phosphatidyl choline(L-a-lecithin from soybean, Sigma 
P-3644) were dispersed in 5.0 ml 50 mM potassium phosphate, 
pH7.4 using a whirlimixer. To this was added 5JlM enzyme. 
This mixture was sonicated using a Heat Systems Sonicator 
3/4 inch probe,. 30 % duty cycle, power 3, for 9 minutes. The 
sample was kept on ice and under a stream of nitrogen during 
sonication. The sonicated mixture was centrifuged at 13,000 
rpm for 10 minutes , using the S8-34 rotor in the Sorvall RC-5 or 
the 870 rotor .in the lEe 8-20A centrifuge(temp. range 2-7°C). The 
clear supernatant from this spin was taken as the sonicated 
vesicles. Using the method described by Nicholls et al (1980), it 
Was determined that total cytochrome oxidase concentration in 
the vesicles was between 3.6J.lM and 4.1 J.lM , and 49% to 500/0 of 
the cytochrome c reaction sites were on the outside of the 
vesicle membrane. The respiratory control ratio was between 5 
and 6.5. 
Po larag raphy 
Turnover studies were carried out by measuring the oxygen 
consumption polarographically with a Clark type oxygen 
electrode(Yeilow Springs Instruments) connected to a polarizing 
box (Brock University electronics shop). The signal was measured 
on either a Radiometer Rec 61 Servograph or a Cole-Parmer 
Versagraph chart recorder. The reaction vessel was a 4.3 ml 
chamber which was magnetically stirred and thermostatically 44 
controlled by a water jacket. When the electrode was placed in 
the reaction vessel, air was excluded from the chamber, leaving 
only a small opening for injection of substrates using a Hamilton 
syringe. 
Spectrophotometry 
I. Spectra of cytochrome c oxidase derivatives 
(a) titrations with valinomycin and dibucaine 
Desired concentrations of cytochrome oxidase were added 
to a 1 cm-lightpath ,1 ml-volume quartz cuvette. Aliquots of 
valin'omycin or dibucaine were added and spectral changes were 
monitored. Spectra were obtained using a Beckman DU-7 
spectrophotometer and stored for later analysis, using a linked 
Apple 11+ or Apple IIGS computer via a domestic data acquisition 
programme(Chanady et al 1985). Appearance of low spin 
cytochrome 83 was followed using the 433-413nm wavelength 
pair. For valinomycin, the apparent dissociation constant, 
Kd(app), and the extinction coefficient ~EmM433-413nm were 
obtained by fitting the data to a user-defined 'Binding' function in 
the MultifiFM v.2.00 (Day Computing • Inc., Milton, Cambridge, UK ) 
package on a Macintosh Classic 68000 device. The derivation of 
this 'Binding' function is as follows: 
Kd(app) = [e]*[L]/[eL] Eq.2 
Where [e] is the free enzyme concentration, [l] is the free ligand 
concentration, [ell is the enzyme-ligand complex concentration. 
Since [eJt=[e]+[eLJ, [Llt = [L]+[eL] (where [eh is the total 
enzyme concentration, [lJt is the total ligand concentration), Eq. 2 45 
can be rewritten as 
Kd{app) = [eJt-[el])*([lh-[el])/[el] 
EmM = .1.A/[el] 
Eq.3 
Eq.4 
Where .1.A is the spectral change induced by the ligand, Em M is 
extinction coefficient of this spectral change. 
Substituting [ell with .1.A/EmM according to Eq. 4, Eq. 3 can 
be again rearranged as : 
.1. A = EmM* {([e h+[lJt+ Kd)-SORT (SOR([ e It+[lJt+Kd)-4* [e 1t *[lJt) }/2 
--------Eq. 5 
Where SORT is the square root of the operand . SOR is the square 
of the operand. Eq. 5 is the 'Binding' function. 
For dibucaine, Kd(app) and EmM433-413nm were obtained both 
by fitting data to Eq. 5 and by using a double reciprocal plot, and 
the results were compared. It is not possible to determine 
Kd (app) and EmM433-413nm for valinomycin by a simple double 
reciprocal plot since the valinomycin concentration used was 
comparable to the enzyme concentration used. 
(b) Dual wavelength spectrophotometric study of the 
kinetics of valinomycin and dibucaine binding with 
cytochrome oxidase 
The kinetics of valinomycin binding with the resting enzyme 
were followed by monitoring the spectral change at the 433-
413nm wavelength pair using an Aminco DW2 UV/Vis 
spectrophotometer, in dual wavelength mode, linked to a Compaq 
286 computer with an Olis™ data acquisition package. Different 
concentrations of valinomycin were added to 4J..LM enzyme in a 46 
1 cm-lightpath , 3ml-volume quartz cuvette to start the reaction. 
The apparent rate constants kapp for the binding were. obtained by 
fitting the trace to a appropriate function in the OIiS™ fitting 
programme. 
·The: kinetios of dibucaine binding with the resting enzyme 
were studied by adding 1.SmM dibucaine to SJ..LM enzyme, then 
monitoring the spectral change at the 433-413nm wavelength 
pair using an Aminco DW2 UV /Vis spectrophotometer(in dual 
wavelength mode), linked to a Compaq 286 computer with an 
OlisTM data acquisition package. A 1 cm-lightpath, 1 ml-volume 
quartz cuvette ,was used. Dibucaine ~nding with the enzyme in 
turnover conditions was studied by monitoring the steady state of 
cytochrome c reduction. Active enzyme concentrations during the 
: shifting cytochrome c steady s.tates which accompany dibucaine 
binding were analysed by the method of Nicholls et al (1974), 
treating the active enzyme species as having a concentration 
proportional to the function [c 2 +]o[c3 +]t/[c3 +]o[c2 +]t, where 
[c2+]o/[c3+]o is the ratio of reduced to oxidized cytochrome c 
immediately before dibucaine( the enzyme inhibitor ) addition, 
and [c2+]t/[c3+lt is the corresponding ratio at any subsequent 
time. 
II. Spectra of cytochrome c oxidase during turnover 
(a) Steady state spectral scan. 
The spectra of cytochrome c oxidase during turnover were 
studied by a Beckman DU-7 spectrophotometer and stored for 
later analysis, using a linked Apple 11+ or Apple JIGS computer via 47 
a domestic data acquisition programme(Chanady et al 1985) . 
Experiments were performed in a 1 cm··lightpath , 1 ml-volume 
quartz cuvette. Reduction was initiated by adding suitable 
concentrations of either ascorbate plus cytochrome c or 
ascorbate plus TMPD to an aerobic solution containing cytochrome 
oxidase. The reduction of cytochrome a ,cytochrome a + a3 , 
and cytochrome c were followed by monitoring the absorbance 
increase at the 605nm band , 445nm band, and 550nm band 
respectively. The reduction of CUA was studied by following the 
absorbance decrease at the 830nm band. After anaerobiosis, 
dithionitewas added to secure the full, reduction of the oxidase. 
The experimental temperature was 30°C. 
(b) Dual wavelength spectrophotometry 
Steady-state studies of the enzyme in turnover were 
performed in an Aminco DW2 UV/Vis spectrophotometer, in dual 
wavelength mode, linked to a Compaq 286 computer with an Oiis™ 
data acquisition package. Experiments were performed in a 1 cm-
lightpath , 1 ml-volume quartz cuvette. Reduction was initiated 
by adding suitable concentrations of either ascorbate plus 
cytochrome c or ascorbate plus TMPD to an aerobic solution 
containing cytochrome oxidase. The reduction levels of 
cytochrome a ,cytochrome a + a3, and cytochrome c were 
followed using the wavelength pairs 605-630nm , 445-470nm and 
550-540nm respectively. After anaerobiosis, dithionite was 
added to secure the full reduction of the oxidase. The 
experimental temperature was 30°C. 
Fluorescence and phosphorescence spectrophotometry 
I. Fluorescence and phosphorescence spectra 
Fluorescence and phosphorescence spectra of resting 
cytochrome oxidase and valinomycin-liganded oxidase were 
obtained using a Perkin Elmer LS-SO luminescence spectrometer 
and stored, using a McCOMP 386 computer with the FLDM data 
acquisition programme, for later analysis. A solution containing 
0.2 JlM resting enzyme, SOmM potassium phosphate, pH 8.0 and 
O.01S% lauryl maltoside was added""to a 1 cm-iightpath, 3ml-
volume fluorescence cuvette. Where indicated, the "oxygen trap" 
was composed of 80nM glucose oxidase, 20nM catalase and O.OS% 
glucose. To minimize the quenching of phosphorescence by 
oxygen, the buffer had been bubbled with pure argon for 20 
minutes before taking phosphorescence spectra and a layer of 
mineral oil was put on the surface of the deoxygenated solution 
to prevent it from contacting the atmosphere again. The spectra 
of the valinomycin-liganded species were taken 40 minutes after 
9JlM valinomycin was added to the solution. The experimental 
temperature was 14°C. The filter position was set at 'clear'. For 
fluorescence spectra, the emission and excitation wavelengths 
were 330nm and 290nm, and both the excitation and emission 
slits were set at S.O nm for phosphorescence spectra, the 
emission and excitation wavelengths were 44Snm and 27Snm , 
the gate time was 5.0ms, and the delay time is 0.2ms. Both 
48 
excitation and emission slits were set at 15 nm to increase the 49 
signal, and the average of 10 scans was taken to produce the 
final result. 
II.Nitrite quenching of phosphorescence of cytochrome 
oxidase± valinomycin. 
Phosphorescence spectra were obtained as above. A 
solution containing 7 J.1M cytochrome oxidase or 7J.1M cytochrome 
oxidase plus 10 J.1M valinomycin, 50mM potassium phosphate, 
pH8.0 and 0.0150/0 lauryl maltoside was added to a 1 cm-lightpath, 
3ml-volume fluorescence cuvette . The buffer had been bubbled 
with pure argon for 20 minutes to rem()\le the oxygen before being 
added to the cuvette, and a "oxygen trap" composed of 80nM 
glucose oxidase , 20nM catalase and 0.05% glucose was also 
included. As described above, mineral oil was put on the top of 
the deoxygenated solution, and during subsequent measurements, 
aliquots of sodium nitrite were added using a Hamilton syringe. 
The phosphorescence emission spectra were measured using 
either 260nm or 295nm as the excitation w~velength. The 
excitation spectra were recorded using 460nm as the emission 
wavelength . The gate time was 3.0 ms , and the delay time was 
OAms. Both the excitation slit and emission slit were set at 
15.0nm . The experimental temperature was 4°C. 
RESULTS 
Part I : Valinomycin-cytochrome oxidase interaction 
A. Spectroscopic effects of valinomycin 
In order to understand the spectroscopic effect of 
valinomycin, control experiments were first carried out with 
conventional ligands. These derivatives were prepared as 
described in Methods and Materials. 
Fig. 4A shows the Soret spectra of the resting enzyme, and 
the formate-liganded, 'pulsed' and cyanide-liganded cytochrome 
oxidase . The absorption maxima are located at 419nm, 416nm, 
424nm and 427nm respectively. Fig. 4B presents the 
corresponding difference spectra. Both 'pulsed' and cyanide-
/iganded enzyme have a peak at 433nm and a trough at 413nm, 
while the formate-liganded enzyme has a peak at 413nm and a 
trough around 433nm, essentially the reverse of the 'pulsed' 
enzyme spectrum. Addition of valinomycin to the resting enzyme 
has a similar effect to that of cyanide. That is , it shifts the 
Soret peak of the oxidase spectrum to the red, although the 
amplitude of the valinomycin effect is less marked(Fig. 5) . 
The time course of the development of the valinomycin 
spectrum is shown in Fig. 6. The difference spectra also have a 
peak around 433nm and a trough at 413nm, as with the cyanide-
liganded species. The development of this valinomycin-induced 
spectral shift takes around 30 min. It can therefore be studied by 
following the absorbance change at the wavelengths of the peak 
and trough positions, i.e. , 433nm and 413nm, where the effect is 
at a maximum. 
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Fig. 4A. Absolute spectra of high and low spin forms of 5 1 
cytochrome oxidase 
The experiments were carried out in 50mM potassium phosphate , 
pH 7.4 , 0.015% lauryl maltoside at 30°C, using the Du-7 Beckman 
spectrophotometer. The enzyme concentration was 4J.LM. The 
pulsed enzyme spectrum was taken 45 minutes after the 
preparation . Formate and cyanide concentrations were 40mM and 
2mMrespectiveJy where indicated. The details of formation of 
'pulsed " formate-liganded and cyanide-liganded enzyme are 
described in Methods. 
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Fig. 4B. Difference spectra of high and low spin forms of 52 
cytochrome oxidase 
The difference spectra were obtained from the absolute spectra 
in Fig. 4A by subtracting the resting enzyme spectrum from the 
spectra of other species. Experimental conditions are as in Fig. 
4A. 
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Fig. 5 Spectra of the resting and valinomycin-Iiganded 
enzyme. 
Experiments were conducted in 50mM potassium phosphate , 
pH7.4, 0.0150/0 lauryl maltoside at 30°C ,using the DU~7 Beckman 
spectrophotometer. The enzyme concentration was 41lM. 100llM 
ferricyanide was· added to the cuvette to keep the enzyme in its 
oxidized form. The spectrum of the valinomycin-liganded species 
was taken 30 mins after 41lM valinomycin had been added to the 
cuvette. 
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complex : Difference spectra(valinomycin-liganded minus 
resting enzyme). 
Experiments were conducted in 50mM potassium phosphate ,pH7.4, 
0.015% lauryl maltoside at 30°C using the DU-7 Beckman 
. spectrophotometer. The enzyme concentration was 4J..LM. Spectra 
were taken at 10sec, 1 min, 3min, 5min, 10min, 20min and 30min 
after 4flM valinomycin had been added to 4J..LM resting enzyme. The 
spectrum of resting enzyme was subtracted from each 
valinomycin spectrum. 
A sample of enzyme was incubated with varying amounts of 55 
valinomycin and the spectral change recorded after 15min. Fig. 7 
plots the corresponding absorbance change as a' function of 
valinomycin concentration. 
In Fig.7A, the results are shown for the reaction in 10mM 
HEPES, while in Fig.7B the corresponding results in the presence 
of 100mM K2S04 are seen. The effect of ionic strength upon the 
valinomycin-induced spectral shift is rather limited. The 
difference extinction coefficient (LlEmM433-413nm) has the same 
value of probably 22mM-1 c m -1 at both high and low ionic 
strengths. The data were fitted to an appropriate "Binding" 
equation in MultifitTM(please see Methods), and the results are 
plotted :as the solid lines in' the two figures. The dissociation 
constant, Kd , for high ionic strength is 2.5JlM , and that for low 
ionic strength is 3.1 JlM. If these parameters are used , the 
resulting curves fit the data quite picely. 
The rate of valinomycin binding was followed in the DW-2 
dual wavelength spectrophotometer. Fig. 8A shows the spectral 
changes as a function of valinomycin concentration. The initial 
rate Vo of the absorbance change at 433-413nm wavelength pair, 
calculated as LlA per minute, varies linearly with valinomycin 
concentration. On the other hand, the apparent rate con$tant k, 
with the dimension sec· 1 , is independent of valinomycin 
concentration and reflects the half time for formation of the 
appropriate fraction of bound enzyme in each case(Fig. 88) . 
The linear relation between initial rate and valinomycin 
Fig. 7 
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Fig. 7 Effect of valinomycin concentration upon the 56 
spectral shift of cytochrome oxidase at high & low ionic 
strengths. 
The experiments were performed in 10mM potassium HEPES, or 
10mM potassium HEPES + 100mM K2S04 buffer, pH7.4 , 0.015% 
lauryl maltoside at 30°C using the DU-7 Beckman 
spectrophotometer . The oxidase concentration was 2.5 JlM . 
Aliquots of valinomycin were added and spectral changes 
recorded after 15 mins incubation. 
The solid lines were obtained by fitting the data with a 
"Binding" function(This function is defined as Eq. 5 in Methods). 
The Muitifit™ fitting programme for the Macintosh was used. 
The extinction coefficients for high and low ionic strengths are 
22.9 ± 4 mM-i c m- 1 and 21.5 ± 2 mM-1 cm -1 respectively. The 
dissociation constant Kd for high ionic strength is 2.8 ±1.0JlM, 
while that for low ionic strength is 3.1 ± 0.7JlM. 
A. titration plot at high ionic strength(10mM potassium 
HEPES + 100mM K2S04. ) 
B. titration plot at low ion ic strength(10mM potassium 
HEPES alone) 
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Fig. BA. Kinetics of valinomycin binding to resting 57 
cytochrome oxidase Time courses of valinomycin 
binding followed at 433 .. 413nm. 
The experiments were carried out in 50 mM potaSSium phosphate I 
pH7.4 , 0.015% lauryl maltoside at 30°C in a DW-2 OIiSTM dual 
wavelength spectrophotometer. 0 - 3.33 JlM valinomycin were 
added to 4.0 JlM enzyme in a 1 cm-lightpath, 3ml-volume quartz 
cuvette to start the reaction as indicated on the trace. Ethanol 
concentration was kept constant at 0.4 0/0. The results of a single 
experiment are shown . Fitted kinetic values are given in Fig. 88. 
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Fig. 88 Kinetics of valinomycin binding to resting 
cytochrome oxidase 
kinetics. 
Analysis of valinomycin binding 
Apparent rate constants kapp for binding were obtained as the 
reciprocals of apparent half times t 1/2 • The initial rate Vo was 
obtained by fitting the curves in Fig. 8(A) with the "straight line" 
function from the Olis™ fitting programme within two minutes 
after adding valinomycin . Data are from the single experiment of 
Fig. 8A. Conditions as in the legend to Fig. 8A. 
58 
concentration indicates that the valinomycin-enzyme interaction 59 
is a 2nd order reaction, which can be described by the following 
equation(Mathews and van Holde 1990): 
E + V 
Where E: enzyme 
enzyme complex 
k1 
~---~ EV 
V: valinomycin 
Eq.6 
EV: valinomycin-
The rate of the formation· of the valinomycin-enzyme 
complex can be described by the following equation: 
d([EV])/dt=k1 *[E]*[V]-k_1 *[EV] Eq. 7 
When t=O, the concentration of EV is insignificant, so the 
contribution of the second item at the right of equation 7 can be 
neglected: 
d([EV])/dtlt=o = k1 *[E]*[V] Eq.8 
The slope obtained from the relation between the initial 
rate Vo and the valinomycin concentration in Fig. 88 is 3.2 b.A 
min-1mM-1. Using the extinction coefficient Em = 22mM-1cm- 1 
obtained from Fig. 7 and an enzyme concentration [E]=4J.lM, k1 can 
be calculated according to Eq. 8 as 600 M-1s·1. As: 
kapp = k1 *[E] + k-1 Eq.9 
Where kapp is the apparent rate constant. 
We have k-1 = 0.0046-600*4*10- 6 = 0.0022s-1. 
Alternatively , if Kd=2.5-3.1 J.lM (Fig. 7), since k-1 = k1 * Kd, if k1 
from Fig. 8 is used, k-1 =0.0015"'0.0019s- 1 . The kinetic and 
equilibrium calculations are thus in essential agreement(Table 1). 
The results are summarized in Table 1. 
What form of valinomycin binds to the enzyme(see Fig. 3 
above)? Fig. 9 shows that under otherwise identical conditions , 
the spectral shift induced by valinomycin is much more marked 
ina potassium medium than in a sodium medium. A much larger 
final spectral change and a faster initial rate are seen in the 
potassium medium(Detailed results are presented in Table 2. ). 
This suggests that the K+ion may be essential to the binding 
between valinomycin and the oxidase, and that the bound form has 
the hexacoordinated cation configuration shown in Fig. 3. 
B. Kinetic effects of valinomycin 
To determine the effect of valinomycin upon the kinetics of 
cytochrome oxidase , the steady state of cytochrome c in the 
presence of reductants, enzyme and oxygen was followed at 550-
540nm (Fig. 10). The steady state reduction of cytochrome c 
increases with the valinomycin concentration indicating 
progressive inhibition. The redox reactions involved in this 
system can be summarized as follows(Nicholls, 1983). 
60 
Table I 
Parameters Fig.8 Fig.? 
(Kinetics) (Equilibrium) 
k1 600M-1 s-1# 
----
kapp 0.00465-1 # 
k - 1 0.0022s- 1 * 0.0015-
0.0019 5- 1 * * 
k-1/k1 3.7llM 
Kd 
----
2.:5-3.1 llM # 
#Direct measurement 
Table 1. Rate constants for valinomycin-cytochrome 61 
oxidase interaction. 
Values listed in the second column are those used for the fittings 
in Fig. 88 . Values listed in the third column are those obtained 
from the fittings in Fig. 7 . Experimental conditions are listed in 
the legends to Figs. 8A and 7 respectively. 
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Fig. 9 Effect of cation composition upon the valinomycin- 62 
induced spectral shift of cytochrome oxidase 
The experiments were carried out in a DW-2 Olis dual wavelength 
spectrophotometer at 30°C. The medium was 50 mM potassium or 
sodium phosphate , pH 7.4. It also contained 0.015% lauryl 
maltoside . The enzyme concentration was 2.5 J.lM and 3.3 J.l-M 
valinomycin was added to a 1 cm-lightpath, 3ml-volume quartz 
cuvette to start the reaction as indicated on the trace. 
Table 2 
Medium ~Am(433- Initial rate 
413nm)* (~A/min)** 
potassium 0.036 4.2E-3 
phosphate 
sodium 0.014 7.9E-4 
phosphate 
Ratio 2.5 5.0 
* Maximal absorbance change(2.5~lM enzyme) 
** Rate of absorbance change(3.3~M valinomycin) 
Table 2. Comparative study of valinomycin-cytochrome 63 
oxidase interaction in different media 
The listed values are obtained from the single pair of 
experiments shown in Fig. 9, using the OlisTM double exponential 
fitting routine. The second column lists the final maximal 
absorbance changes at the indiacted wavelengths. The third 
column lists the initial rates of absorbance change. All conditions 
are given in the legend to Fig. 9. 
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Fig. 10. Effect of valinomycin upon steady state enzyme 64 
activity. 
The experiments were performed in 50mM potassium phosphate, 
pH 7.4 , 0.015% lauryl maltoside and 13J.lM cyt. c at 30°C. 1.5J.lM 
cyt. aa3 was incubated at the desired valinomycin concentration 
for 1.0 h before 10mM ascorbate was added to start the reaction. 
The reduction of cytochrome c was monitored ~t the 550-540nm 
wavelength pair, using the DW-2 dual wavelength 
spectrophotometer. A 1cm-lightpath,1 ml-volume quartz cuvette 
was used to hold the reaction mixture. The figure shows the 
results of a single experiment. Replicates give similar results 
(steady state values differing by no more than ± 5%). 
Cytochrome c is reduced by ascorbate according to Eq. 10: 
AH2 + 203+-----7 A + 02+ + 2H+ Eq. 10a 
Eq. 10b 
where AH and A are reduced and oxidized forms of ascorbate 
respectively, v is the velocity, kr is the rate constant for 
reduction. 
Cytochrome c is reoxidized by cytochrome oxidase 
according to Eq.11{Minnaert 1961): 
02 
02+ + e~---702+e ---7 O3+e ~---7 e + 03+ Eq.11 a 
v=kO[c2+]e/(Km+[chotal)= 4[02]/tanaerobic Eq.11b 
Where ko is the rate constant for oxidization of ferrous 
cytochrome c by the oxidase, Km is the Michaelis constant for 
cytochrome c and tanaerobic is the time taken for the solution to 
become oxygen-free. 
In Fig. 11 A, kr , the rate constant of reduction of 
cytochrome c by ascorbate was calculated from Eq. 10b and 
plotted against valinomycin concentration. Valinomycin has little 
effect on kr, indicating that the inhibition does not occur at this 
step. The average value of kr under these conditions was 80M-1 
s-1. On the other hand, ko , the rate constant for oxidization of 
ferrous cytochrome c by the oxidase, decreases substantially 
with an increase in valinomycin concentration (Fig. 11 B). But 
even at a high valinomycin concentration, there is still some 
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Fig. 11. Kinetic analysis of the effects of valinomycin 66 
upon the ascorbate-cytochrome c-cytochrome 883-02 
steady state. 
A. Reduction of cytochrome c by ascorbate. 
The second order reduction rate constants were calculated from 
the steady state data of Fig, 10 according to the method described 
on p.65 of the Resu Its. The straight line is drawn for a constant 
kr value of 81 M-1 s-1, Conditions are as in the legend of Fig.10. 
Error bars are not shown (see Fig. 10 legend ). 
B. Enzymatic activity (turnover). 
The turnover number ko is the oxidation rate constant calculated 
according to the method described on p.65 of the Results, The 
theoretical curve is drawn for a Kd of 1 Jl.M and a residual activity 
of 45%. Conditions are as in the legend of Fig. 10. Error bars are 
not shown (see Fig. 10 legend ). 
residual enzyme activity. The maximum percentage inhibition is 67 
approximately 55%, and the Kj, the valinomycin concentration 
causing half of the maximum inhibition, is estimated as 
1.0JlM(see fitted curve, Fig.11 B) . 
The valinomycin effect upon electron transfer in the 
absence of cytochrome c was investigated by following the 
steady state reduction of cytochrome a by ascorbate plus TMPD 
at 605-630nm (Fig. 12). A relatively low buffer concentration 
(10mM potassium phosphate) was used to promote the reaction 
velocity without adding too high a concentration of reductant. The 
steady state reduction of cytochrome a increases from 230/0 in 
the control condition to 28% in i! the presence of 10JlM 
valinomycin. The anaerobiosis time also increases when 
valinomycin is present, indicating an inhibition of the intrinsic 
enzyme activity in the absence of cytochrome c. 
Valinomycin is both an ionophore, and, as shown above, an 
inhibitor of cytochrome oxidase. It is therefore important to 
understand the relationship between these two functions of 
valinomycin. The respiration rate of cyto~hrome oxidase-
containing proteoliposomes was studied over a wide range of 
valinomycin concentration (up to 8.5JlM) , using the 02 electrode 
method(Fig. 13). When another ionophore , either FCCP or 
nigericin, is present, less than 0.1 JlM valinomycin is enough to 
stimulate fully the respiration of the proteoliposomes. As the 
valinomycin concentration is increased, a partial inhibition of the 
FCCP or nigericin-stimulated rate , giving a 20% decrease of the 
maximal respiration rate, is observed. Kj, the valinomycin 
Fig. 12 
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Fig. 12 Steady state reduction of cytochrome a induced 68 
by TMPD: action of valinomycin. 
The experiments were conducted in 10mM potassium phosphate • 
pH 704, 0.015% laury! maltoside at 30°C. 3.1 j..LM cytochrome aa3 
was incubated in 10j..LM valinomycin for 30 min before 10mM 
ascorbate plus OAmM TMPD were added to start the reaction. The 
reduction of cytochrome a was monitored at 605-630nm 
wavelength pair, using DW-2 dual wavelength spectrophotometer. 
A 1 cm-lightpath, 1 ml-volume quartz cuvette was used to hold the 
reaction mixture. 
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Fig. 13. Respiration rates 
containing proteoliposomes: 
of cytochrome 
influence of 
oxidase-
different 
valinomycin concentrations in presence and absence of 
FCCP and nigericin. 
Polarographic experiments were carried out with sonicated COV 
prepared as described in Methods, with lipid:protein ratio=25:1 
and 49% cytochrome aa3 externally-facing. The reaction medium 
was 50mM potassium phosphate, pH 7.4, with 9 nM (total) aa3 , 
10 J.lM cytochrome c , 1.0J.lM FCCP and 0.16J.lM nigericin where 
indicated. The valinomycin concentrations range from 0.0 to 
8.5J.lM. The experimental temperature was 30 c C. The figure shows 
the results of a single set of experiments. Similar experiments 
give essentially similar results. 
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concentration required to cause a half maximal effect ,is 70 
estimated as 1.0j..lM. 
When valinomycin alone is present, the respiration rate 
increases slightly with increasing concentrations of valinomycin 
up to approximately 2j..lM. The Kd for this effect, the valinomycin 
concentration required to cause a half maxima! increase, is about 
0.2j..lM. It may be noted that the maximal activity in the absence 
of either FCCP or nigericin is about 50% that in their presence 
and 40% of the maximal activity at the lowest concentrations of 
valinomycin. 
c. Protein fluorescence and pho9phorescence effects of 
valinomycin-cytochrome oxidase interaction 
Protein fluorescence and phosphorescence have proven to 
be very· useful as monitors of protein conformation(Lakowicz 
1983, Papp and Vanderkooi 1989). Fig. 14A shows that the 
fluorescence excitation spectrum of cytochrome oxidase has a 
peak at 281 nm , which is close to the normal protein absorption 
peak. After adding the "oxygen trap", a slight increase of intensity 
can be seen, but the peak pOSition does not change. Valinomycin 
causes a slight quenching but does not change the peak position 
either. The position of the emission spectrum peak(Fig.14B) is 
located at 336nm when 883 alone is present, but it moves to 
338nm when the " oxygen trap" is added. The "oxygen trap" also 
causes a broad intensity increase in the longer wavelength range 
above 338nm, which is probably due to strong fluorescent 
interference from flavin groups in glucose oxidase in the 
Fig. 14(A) 
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Fig.14A. Fluorescence excitation spectra of cytochrome 71 
oxidase ± valinomycin 
Fluorescence spectra were obtained using a Perkin Elmer LS-SO 
luminescence spectrometer and stored, using a McCOMP 386 
computer with the FLDM data acquisition programme, for later 
analysis. 0.2 }lMaa3 0 was added to a 1 cm-lightpath, 3ml-volume 
fluorescence cuvette containing 50mM potassium phosphate, pH 
8.0 and ·0.01S% lauryl maltoside. Where indicated, the "oxygen 
trap" was composed of 80nM glucose oxidase, 20nM catalase and 
O.OS% glucose. The spectra of the valinomycin-liganded species 
were taken 60 min after 9~lM valinomycin was added to the 
solution. The experimental temperature was 14°C. 80th the 
excitation slit and the emission slit were S.Onm. The filter 
position is 'clear'. The Y axis unit is arbitrary. The emission 
wavelength = 330nm. 
Fig. 14(8) 
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Fig.14B Fluorescence emission spectra of cytochrome 72 
oxidase ± valinomycin 
The excitation wavelength = 290nm. Other conditions were 
identical as those of Fig. 14A. 
"oxygen trap". Valinomycin causes a slight quenching (8%) of the 73 
intensity at the 338nm peak , and has very little effect in the 
longer wavelength range. 
Recently room temperatu re phosphorescence from 
cytochrome oxidase has been reported(Papp at ai, 1991) and 
,suggested to be a more selective probe of protein structure than 
fluorescence. Fig .15A shows that phosphorescence excitation 
spectra of 883.883 +"oxygen trap", and 883 + "oxygen 
trap"+valinomycin all have a peak position at 275nm, so that if 
excited at 275nm, the emission spectra should give the maximal 
signal. The emission spectra (Fig.15B) show two peaks. The 
smaller peak around 340nm is most probably due to a contribution 
from fluorescence, since the fluorescence emission spectra also 
have a peak around this wavelength(see Fig. 14B) . But the 
intensity has dropped from 65(arbitrary unit) to 0.1, indicating 
that the lifetime of this signal is very short. On the other hand, 
the bigger peak around 447nm is the true phosphorescence peak, 
which has a longer lifetime. Adding the "oxygen trap" or 
valinomycin causes a slight increase of the intensity of both 
peaks, but the peak positions are not affected. 
In order to understand better the valinomycin-induced 
conformational change of the enzyme , NaN02 quenching behaviour 
towards cytochrome oxidase in the absence and presence of 
valinomycin was also investigated (Fig. 16). Some experimental 
conditions were slightly changed to optimize the phosphorescence 
signal. The 883 concentration was increased from 0.2jlM to 7jlM 
to increase the signal, and the experimental temperature was 
Fig. 15(A) 
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Fi g. 1 SA Phosphorescence excitation spectra of the 74 
deoxygenated cytochrome oxidase ± valinomycin 
Phosphorescence spectra were obtained using a Perkin Elmer LS-
50 luminescence spectrometer and stored, using a McCOMP 386 
computer with the FLDM data acquisition programme, for later 
... analysis. 0.2 J.l.M aa3 . was added to a 1 cm-lightpath, 3ml-volume 
fluorescence cuvette containing SOmM potassium phosphate, pH 
8.0 and 0.015% lauryl maltoside. The buffer had been bubbled with 
pure argon for 20 min to remove the oxygen before being added to 
the cuvette, then a layer of mineral oil was put on the top of the 
deoxygenated solution to prevent it from contacting the 
atmosphere. Where indicated, the "oxygen trap" was composed of 
80nM glucose oxidase, 20nM catalase and O.OS% glucose. The 
spectra of valinomycin-liganded species were taken 30 min after 
9JlM valinomycin was added to the solution. The experimental 
temperature was 14°C. 80th the excitation slit and emission slit 
were 1S.0nm. The V axis unit is arbitrary. Average of 10 scans 
were taken in each case. The Gate time = 5.0ms . Delay time = 
0.2ms . The emission wavelength = 44Snm. 
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Fig.1 5 B Phosphorescence emission spectra of the 75 
deoxygenated cytochrome oxidase ± valinomycin 
The excitation wavelength = 275nm. Other conditions were 
identical with those of Fig. 15A. 
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Fig. 16 NaN02 quenching of phosphorescence of 76 
cytochrome oxidase ± valinomycin 
Phosphorescence spectra were obtained using a Perkin Elmer LS-
50 luminescence spectrometer and stored, using a McCOMP 386 
computer with the FLDM data acquisition programme, for later 
." analysis. 7 J..LM aa3 or 7JlM aa3 plus 10 J..LM valinomycin was added 
to a 1cm-lightpath, 3ml-volume fluorescence cuvette containing 
50mM potassium phosphate, pH8.0 and 0.0150/0 lauryl maltoside. 
The buffer had been bubbled with pure argon for 20 min to remove 
the oxygen before being added to the cuvette, and a "oxygen trap" 
composed of 80nM glucose oxidase , 20nM catalase and 0.05% 
c •. " • . glucose was ·also included ... A layer of .mineral oil was then put on 
the top of the deoxygenated solution to prevent it from contacting 
the atmosphere. During subsequent measurements, aliquots of 
NaN02" were added using a' Hamilton syringe. The phosphorescence 
emission spectra were measured using either 260nm or 295nm as 
the excitation wavelength. The excitation spectra were recorded 
using 460nm as the emission wavelength. The gate time was 3.0 
ms , and the delay time was O.4ms. Both the .excitation slit and 
emission slit were 15.0nm. The experimental temperature was 
4°C. Background contribution has been subtracted from all the 
data. The Y axis unit is arbitrary. 
decreased from 14°C to 4°C for the same reason; the decay of the 
protein phosphorescence is much faster at higher temperatures 
(Papp and Vanderkooi 1989). The delay time was increased from 
0.2 ms to 0.4 ms to decrease the interference from the 
fluorescence signal. 
" Since the concentration o'f aa3 is rather high (7J,lM aa3 
corresponds to about 1.4 mg/ml protein concentration), the 
phosphorescence excitation spectrum peak is no longer located at 
275nm due to severe light reabsorption. So instead of using 
275nm as the excitation wavelength, the two wavelengths 260nm 
and 295nm , which correspond to artificial maxima in the 
excitation spectrum, were used for.'llexcitation in emission 
spectral scans. Fig.16 shows that when 295nm was used. as the 
excitation wavelength, the NaN02 quenching behaviour was not 
changed by the presence of valinomycin. The percentage of 
maximal quenching is 37%, while the quenching constant KD , the 
reciprocal of the nitrite concentration required to have a half 
maximal effect , is estimated as 0.033J,lM-i. 
On the other hand, when 260nm was used as the excitation 
wavelength, the percentage of maximal quenching decreases from 
340/0 to 14%, while the quenching constant KD increases from 
0.04 J.lM-1 to 0.1 J.lM-1 when valinomycin is present. The detailed 
results are summarized in Table 3. 
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Excitation 
wavelength 
260nm 
295nm 
Table 3 
Additions 
none 
(control) 
pll:'s 
valinomycin 
none 
(co ntrol) 
plus 
valinomycin 
0.04 
0.1 
0.033 
0.033 
Maximum % 
quenching 
340/0 
140/0 
37% 
370/0 
Table 3. Nitrite quenching of phosphorescence of 78 
cytochrome oxidase ± valinomycin 
The apparent quenching constants listed in column three are the 
reciprocals of the nitrite concentrations giving half maximal 
effects. The quenching percentages listed in column four are the 
maximal values reached at high nitrite concentrations. The 
actual values in both columns are those used in the fits shown in 
Fig. 16. The conditions are presented in the legend to Fig. 16. 
Part II : Dibucaine-cytochrome oxidase interaction 
A. Spectroscopic effects of dibucaine 
Dibucaine contains a heterocyclic structure and two 
hydrophobic chains: 
Cl1CH3 
o = c · NHCHPH2~CH2CH3 
The absorption spectrum of dibucaine(Fig.17 A) shows that 
it absorbs in the UV region(below 370nm) , but not in the visible 
region . The chromophore is presumably the heterocyclic ring 
which contains conjugated bonds. The absorption values at 290nm 
and at 330nm increase linearly with dibucaine 
concentration(Fig.17B) , indicating that the Beer-Lambert law is 
observed. The slope of the line, which represents the extinction 
coefficient Em M, can be obtained by fitting the data to the 
'Simple' function in the CricketTM programme : 
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EmM290nm = 5.50mM-1cm-1 
EmM330nm = 7.80mM-1cm-1 
and 
The above values are helpful in estimating concentrations of 
dilute dibucaine solutions. 
It has been reported that Kj for the dibucaine-oxidase 
, interaction, is in millimolar range(Ghazotte and Vanderkooi 1981 ; 
Singer 1980,1982 and 1983; Stringer and Harmon 1990). At the 
effective millimolar concentration range , dibucaine absorption in 
the UV region (260nm-330nm) will be over 5.0A based on the 
extinction coefficients listed above . Since the excitation 
wavelengths for cytochrome c oxidase are located in this 
region (Papp et al 1991), it is impos~ble to conduct an enzyme 
fluorescence or phosphorescence study because of the severe 
interference from the dibucaine absorption. 
On the other hand, because dibucaine does not absorb in the 
visible region (Fig.17 A) , where the spectra of the metal centres 
of cytochrome c oxidase are located, the dibucaine-induced 
spectral changes of the enzyme can be studied 
spectrophotometrically in a similar way to those of valinomycin. 
Dibucaine induces a red shift of the enzyme's Soret peak 
like that with valinomycin (Fig. 18). The difference spectra show 
a progressive spectral change with time (Fig. 19). But unlike the 
valinomycin-induced spectral shift(Fig. 6), the kinetic behaviour 
of this spectral shift is more complicated The isosbestic point 
of the difference spectra shifts with 
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Fig. 17 A.Absorption spectra of dibucaine. 
Dibucaine concentrations between 6 and 42 ~M, as indicated . 
Measurements in 50mM potassium phosphate, pH 7.4 and 0.015% 
lauryl maltoside at 30 o G. DU-7 Beckman spectrophotometer: 
1 cm-lightpath, 1 ml-volume cuvette 
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Fig. 17B Absorbance change as a function of dibucaine 82 
concentration : 
Data from Fig. 17 A. Buffer contribution to absorption is 
subtracted from all the data. Conditions as in the legend to Fig. 
17 A. Conditions are as in the legend to Fig. 17 A. 
co 
,... 
. 
C) 
u:: 
CD 
() 
c 
as 
.0 
Ito. o~ (I) 
.0'" 
c( 
a 
c 
CD 
C 
.-as 
~~ 
.-Q 
+ 
at) 
0 
o ,.. 
qo 
0 
Ol 
OM 
. 
0 
-E 
c 
-.c 
-a 
c 
CD 
-CD 
> as 
3= 
Fig. 18 Absolute spectra of resting enzyme and dibucaine 83 
-liganded enzyme. 
Experiments in 50mM potassium phosphate,pH 7.4, 0.015% lauryl 
maltoside at 30°C, with 4~lM resting enzyme. 1 OO~M ferricyanide 
was added to keep the enzyme in the oxidized form. The spectrum 
of the dibucaine-liganded species was taken 30 min after 2mM 
dibucaine was added to the cuvette. DU-7 Beckman 
spectrophotometer; 1 cm-lightpath, 1 ml-volume cuvette 
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Fig.19 Difference spectra of dibucaine-liganded species 84 
minus resting enzyme. 
Experiments in SOmM potassium phosphate,pH 7.4, O.01S% lauryl 
maltoside at 30°C with 4J.LM resting enzyme . Spectra were taken 
at 10sec, 1 min, 2min, 3min,Smin, 10min, 20min and 30min after 
.. addition:of 1.SmM dibucaine. The spectrum of resting enzyme was 
subtracted from each spectrum. DU-7 Beckman 
spectrophotometer; a 1 cm-Iightpath, 1 ml-volume quartz cuvette. 
time , suggesting a multiphasic process . The peak was originally 85 
located at 430nm, and then it slowly shifted to 436nm. The 
trough stayed at 413nm. In this respect the dibucaine effect 
differs from the valinomycin effect, which appears to result in a 
single final species (Fig. 8A) . The rate of dibucaine binding was 
studied. by monitoring the spectral change at the 433-413nm 
wavelength pair instead of 436nm-413nm (Fig. 20A), in order to 
be consistent with the parallel study with valinomycin(Fig. 8A) . 
When dibucaine was added to the enzyme, a biphasic trace was 
obtained. The data were fitted to a double exponential rise 
function in the OIiS™ fitting programme. The values of the 
maximal spectral change 6A and the brate constant kapp for the 
fast phase can be calculated as 0.01 A and 0.019 sec- 1 
respectively, while 6A and kapp for the slow phase are 0.07A and 
0.00019 sec- 1 . The corresponding logarithmic plot is shown in 
Fig. 20(8). Assuming that kapp =-slope/log(e) = - 2.303 * slope, 
the result is very close to that obtained by direct fitting. 
Formate alone induced a opposite spectral shift to that with 
dibucaine with a total 6A of 0.036. When formate was added after 
dibucaine addition , the dibucaine-induced red shift was partially 
reversed with a total !::.A of 0.055 . The data were fitted to a 
double exponential decay function in the OIiSTM fitting routines . 
The corresponding logarithmic plots are shown in Fig. 20C. The 
rate constants for the formate effect changed very little in the 
presence of dibucaine, indicating that dibucaine does not hamper 
formate binding at the binuclear centre . 
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Fig. 20(A) Time course of dibucaine binding to resting 
cytochrome oxidase: comparison with formate binding. 
Experiments in 50 mM potassium phosphate , pH7.4 , 0.015% 
lauryl maltoside at 30°C with 1.5 mM dibucaine or 3mM sodium 
formate added to 5.0 JlM resting enzyme to start the reaction. At 
the end of the dibucaine reaction , 3mM sodium formate was also 
added to compare the formate and dibucaine effects. Spectral 
changes monitored at 433-413nm . DW-2 Olis dual wavelength 
spectrophotometer; 1 cm-lightpath, 1 ml-volume cuvette. 
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Fig. 20(8) Analysis of dibucaine binding kinetics 
logarithmic plots of the differential absorbance changes. 
Experimental data from the results in Fig. 20(A). The end point 
(maximal absorbance change) was estimated using the Olis™ 
fitting routine for a double exponential rise function (see 
Methods). Starting 10g(L\Am-L\A) arbitrarily set to 0.00. The 
straight line shows the results of the fit, to the chosen 
experimental points (closed symbols). 1.5mM dibucaine plus 5.0JlM 
resting enzyme at 30 0 G pH 7.4. 
Fig. 20(G) Analysis of 
logarithmic plots of 
ch anges(±d ibucaine). 
formate binding 
the differential 
kinetics 
absorbance 
Experimental data from the results(inverted from absorbance 
decrease) in Fig. 20(A). The end points (maximal absorbance 
changes) were estimated using the OlisTM fitting routine for a 
double exponential rise function (see Met hod s). Starting 
log (L\Am -L\A) arbitrarily set to 0.00. The straight line shows the 
results of the fit to the chosen experimental points (closed 
symbols: with dibucaine; open symbols: control). 3.0mM sodium 
formate plus 5.0JlM resting enzyme at 30 0 G pH 7.4 ± dibucaine. 
Other conditions as in the legend to Fig.20(A). 
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Fig.21 A plots the spectral changes at 433-413nm in SOmM 88 
potassium phosphate buffer as a function of dibucaine 
concentration . The dissociation constant Kd and the maximal 
extinction coefficient .1EmM can be obtained from Eq. 12: 
Kd'= [E]*[O]/[EO] Eq.12 
. Since .1Amax = [E]tot*EmM, .1A=[EO]*EmM, and [E]tot=[E]+[EO], 
we have: 
1/.1A = (Kd/.1Amax)/[O] + 1/.1Amax Eq. 13 
According to Eq. 13, a double reciprocal plot, i.e. 1/AA vs . 
. . -1/[0] -will result ina· straight line. The Y axis intercept is the 
reciprocal of .1Amax, which can be used to calculate .1EmM. The X 
axis intercept is the reciprocal of Kd. Fig. 21B shows that 1/.1A 
changes-linearly with 1/[D]. The' apparent dissociation constants 
K d and extinction coefficients .1Em M can also be obtained by 
fitting the data directly to an appropriate "Binding" equation in 
MultifitTM(see Methods for details). 
The effect of ionic strength was investiga~ed by monitoring 
the spectral change at two different buffer concentrations(Fig. 
22A). The apparent dissociation constants Kd and extinction 
coefficients AEm M were obtained using the two methods 
described above. Fig. 22B is the double reciprocal plot of the data 
from Fig. 22A. 
The results from Figs. 21 and 22 are summarized in Table 
4. The parameters obtained by direct fitting and from the double 
reciprocal plot are in essential agreement. Although the ionic 
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Fig. 21 Effect of the dibucaine concentration on the 
magnitude of the cytochrome oxidase spectral shift 
Experiments in 50 mM potassium phosphate, pH7.4, 0.0150/0 lauryl 
maltoside at 30°C . Separate aliquots of 3.9 JlM enzyme were 
incubated at the indicated dibucaine concentrations for 2 hours . 
DU-7 Beckman spectrophotometer; 1 cm-lightpath, 1 ml-volume 
cuvette . 
A. titration curve(spectral change at 433-413nm) 
B. double reciprocal plot(spectral change at 433-413nm) 
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Fig. 22 Effect of ionic strength upon 
induced enzyme spectral shift 
the dibucaine-
Two sets of experiments were carried out in 10 mM or 150mM 
potassium phosphate , pH7.4, respectively, with 0.015% lauryl 
maltoside at 30°C . Separate aliquots of 3.9 J.LM enzyme were 
incubated at the indicated dibucaine concentrations for 2 hours . 
DU-7 Beckman spectrophotometer; 1 cm-light~ath, 1 ml-volume 
cuvette . 
A. Titration curve (spectral change at 433-413nm). 
Open symbols : 150mM potassium phosphate. 
Close symbols : 10mM potassium phosphate. 
B. Double reciprocal plot (spectral change at 433-413nm). 
Open symbols : 150mM potassium phosphate. 
Close symbols : 10mM potassium phosphate .. 
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Table 4 
potassium By direct By the double fitting reciprocal plot phosphate 
LlE LlE (mM) Kd(mM) (433-413nm) Kd(mM) (433-413nm) 
10* pA7±0.07 
7.51 ±O.5 
0.56±0.OS S.23±O.7 
- 1 - 1 - 1 - 1 
mM em mM em 
50 # 0.65±0.O6 9.55±O.26 p.62±0.07 9.40±OA 
- 1 - 1 - 1 - 1 
mM em mM em 
150 * 0.72±O.1 10.02±1.0 p.76±O.OS 10.35±0.8 
- 1 - 1 - 1 - 1 
mM em mM em 
* Values are from Fig. 22. 
# Values are from Fig. 21. 
Table 4. Dibucaine-induced spectral changes in the media 9 1 
of different ionic strengths. 
The values in the second row are obtained from the data of Fig. 
21. The values in the first and third rows are obtained from the 
data of Fig. 22. Columns two and three list the apparent 
dissociation constants (Kd values) and maximal absorbance 
changes obtained from the MultifitTM direct fitting routine. 
Columns four and five list the corresponding dissociation 
constants (Kd values) and maximal absorbance changes obtained 
from the double reciprocal plots shown in Figs 21 Band 22B. All 
conditions are listed in the legends to Figs. 21 and 22. 
strength varied from 10mM potassium phosphate to 150mM 92 
potassium phosphate , Kd and ~Em M changed only slightly, 
indicating that electrostatic forces are not the major factor 
which determines the dibucaine ~oxidase interaction. 
The apparently similar spectral effects of dibucaine, 
valinomycin and cyanide upon resting cytochrome oxidase(Figs. 
4A, 5 and 18) prompted some parallel spectral studies under 
enzymatic turnover conditions. To avoid complications from the 
presence of cytochrome c , an artificial reducing system 
composed of ascorbate plus TMPD was used. Ascorbate was added 
in excess to keep the enzyme substrate TMPD completely in its 
colorless reduced form. 1 0 secon~s after adding reducing 
equivalents to the resting enzyme, 69 % of the cytochrome a 
was reduced(Fig.23A), evidenced by a substantial absorption 
increase at both 445nm and 604nm . In the later steady state(8 
min after adding reducing equivalents), cytochrome a became 
slightly reoxidized, indicating that the enzyme had become more 
active . The 445nm band of the reduced enzyme is due to both a 
and as in roughly equal proportions(Yon~tani 1960), so 
cytochrome a3 remained mostly oxidized during the steady state 
since the 445nm band developed to only about half of its possible 
maximum . The 419nm band moved to 424nm during the steady 
state. This phenomenon was explained by Nicholls and Hildebrandt 
(1978a) as a high to low spin shift of the ferric as as a result of 
a enzyme conformational change during the steady state. When 
formate, a conventional ligand for high spin haem a3, was added 
to the resting enzyme, a blue shift of the Soret peak from 419nm 
Absorbance 
0.5 
0.4 
0.3 
0.1 
Reduced 
A. 'III ! Later steady state 
fI 
Initial steady state 
Fig. 23(A) 
« 
N 
o 
. 
o 
Reduced 
.. 
~ 'l: Oxidized 
0.01~--------~:-:-----------'-------------I 
390 490 590 690 
Wavelength(nm) 
Fig. 23A The early and late steady state behaviour of 93 
cytochrome oxidase control 
The experiments were performed in 50 mM potassium phosphate, 
pH 7.4, 0.015% lauryl maltoside· at 30°C with 14 mM ascorbate 
plus 0.27 mM TMPD added to 3 )lM oxidase in a 1cm-iightpath, 
.1 ml-volume quartz cuvette. DU-7 Beckman spectrophotometer. 
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Fig. 238. The early and late steady state behaviour of 94 
cytochrome oxidase : in the presence of formate 
14 mM ascorbate plus 0.27 mM TMPD were added to 3 J.lM oxidase 
in presence of 40mM formate, other conditions are identical as 
those of Fig. 23A. 
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Fig. 23C. The early and late steady state behaviour of· 95 
cytochrome oxidase : in the presence of dibucaine 
14 mM ascorbate plus 0.27 mM TMPD were added to 3 llM oxidase 
in presence of 1.SmM dibucaine, other conditions are identical as 
those of Fig. 23A. 
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Fig. 23D The early and late steady state behaviour of 96 
cytochrome oxidase : in the presence of valinomycin 
14 mM ascorbate plus 0.27 mM TMPD were added to 3 J..lM oxidase 
in presence of 4J..lM valinomycin, other conditions are identical as 
those of Fig. 23A. 
to 417nm was seen(Fig. 238), indicating a low to high spin shift 97 
of ferric 83 (Nicholls 1976) . Formate also kept cytochrome 83 in 
the high spin form during the steady state, so that the 417nm 
band remained at the same wavelength. A higher 605nm band and 
a well-developed trough between the 417nm and 445nm bands 
indicate that cytochrome 8 was much more reduced(>90% , see 
Fig.24) during the formate-inhibited steady state compared with 
control conditions, due to the inhibition of electron transfer 
between cytochrome 8 and the binuclear center (Nicholls 1976). 
In the presence of dibucaine(Fig. 23C) , the initial steady state 
spectrum showed a higher 605nm band and a more marked split of 
the 419nmand 445nm bands tha(1j in control conditions, 
indicating inhibition of electron transfer. The later steady state 
spectrum is similar to that in control conditions, and features a 
. decrease of absorption at both 605nm and 445nm as well as a red. 
shift of the Soret peak from 419nm to 424nm . The valinomycin 
effect is similar to that of dibucaine (Fig. 23D); a slight increase 
in the steady state of cytochrome a was also seen, which is 
consistent with the previous observations when the cytochrome 8 
steady state was monitored at the 605-630nm wavelength 
pair(Fig. 12). 
From the above experiments as summarized in Fig. 24, it is 
clear that although both dibucaine and valinomycin have similar 
effects upon the resting enzyme spectrum to those of 
conventional low spin haem ligands such as cyanide and azide, the 
two former ligands exhibit quite different spectral behaviour 
during the steady state. Although they cause a slight increase in 
Fig. 24 
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Fig. 24. Cytochrome a steady states in the presence of 98 
different ligands 
Values are obtained from the sets of scanned spectra shown in 
Fig. 23, using the differences between the absorbances at 604nm 
and 630nm and calculating the percentage of reduced cytochrome 
a by assuming that 85% of the llA after anaerobiosis is due to 
reduced cytochrome a (Yonetani 1960). This summary figure 
shows the results of a single set of experiments. Similar 
experiments give similar results (steady state values differing 
by no more than ± 5%). All conditions are listed in the legends to 
Fig. 23A, B, C and D . 
the steady state of reduced cytochrome a, dibucaine and 99 
valinomycin have no dramatic effects upon the steady state 
pattern . On the other hand, the 419nm peak disappears in the 
later steady state spectrum when cyanide· or . azide is present 
(Nicholls and Hildebrandt 1978a), and a small shoulder at 430nm 
develops. 
B. Kinetic effects of dibucaine 
The inhibition of cytochrome oxidase activity by dibucaine 
has been extensively studied by Singer(1980, 1982, 1983) using 
an oxygen electrode technique. The inhibition can also be studied 
by monitoring the cytochrome c redox steady state at 550-
540nm spectrophotometrically (Fig. 25) .. Employing a similar 
method to that used to study inhibition by valinomycin , kr{see 
Eq.4b) , the rate constant for reduction of cytochrome c by 
ascorbate, is plotted against dibucsine concentration (Fig. 26A). 
The value of kr changes very little with increasing dibucaine 
concentration, suggesting that dibucaine does not inhibit 
electron transfer between ascorbate and cytochrome c. The 
progressive decrease in ko ( the rate constant for oxidization of 
ferrous cytochrome c by the enzyme) with increasing dibucaine 
concentration (Fig. 26B) confirms the previous observation 
(Singer 1980, Stringer and Harmon 1990) showing that dibucaine 
is an oxidase inhibitor . This inhibition is not an artifact caused 
by the artificial electron donor systems used in this and other 
studies The maximum percentage inhibition is approximately 
80%, and the Ki , the calculated dibucaine concentration causing 
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Fig. 25. Effect of dibucaine upon 
activity. 
steady state enzyme 100 
The experiments were performed in 50 mM potassium phosphate, 
pH=7.4, 0.015% lauryl maltoside at 30°C ~12JlM cytochrome c and· 
1 JlM oxidase were incubated at the desired dibucaine 
,concentration(0-2.0mM) for 30 mins before adding 10mM 
ascorbate to start the reaction. 1 cm-lightpath , 1 ml volume 
quartz cuvette ; DW-2 dual wavelength spectrophotometer. 
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Fig. 26. Kinetic analysis of the effects of dibucaine upon 101 
the ascorbate-cytochrome c-cytochrome 883-02 steady 
state. 
A. Reduction of cytochrome c by ascorbate. 
The second order reduction rate constants were calculated from 
the steady state data of Fig. 25 according to the method described 
on p. 65 of the Results. The straight line is drawn for a constant 
, 
kr value of 68 M-1 s-1. Conditions are as in the legend of Fig.25. 
Error bars are not shown . 
B. Enzymatic activity (turnover). 
The turnover number ko is the oxidation rate constant calculated 
according to the method described on p.65 of the Resu Its . The 
theoretical curve is drawn for a Kd of 0.7mM and a residual 
activity of 20%. Conditions are as in the legend of Fig. 25. Error 
bars are not shown. 
half of maximal inhibition is estimated as O.7mM ( see fitted 102 
curve, Fig. 268). 
The rate constant for cyanide binding is greatly enhanced 
under enzymatic turnover conditions(Nichoils and Chance 1974}. 
Does the presence of reducing equivalents have the same 
accelerating effect on dibucaine binding with the enzyme? Fig. 
27(A) shows that under turnover conditions, dibucaine causes a 
biphasic increase of cytochrome c reduction in its steady state , 
with apparent rate constants of 0.08 sec- 1 and 0.0018 sec- 1 
73% of the rise is the fast phase, 27% is the slow phase. These 
data were obtained by fitting the data to a double exponential 
rise function in the OlisTM programme. These rate constants are 
four times greater and ten times greater respectively than the 
corresponding rate constants for the spectral shift. Since the 
steady state of cytochrome c reflects the percentage of the 
active enzyme (Nicholls and Chance q1974), the rise in the reduced 
cytochrome c steady state can be explained by gradual binding of 
dibucaine to the enzyme. The apparent rate constants obtained 
above can thus be treated as the apparent rate constants for 
dibucaine binding. So the presence of reducing equivalents indeed 
increases the rate of dibucaine binding , as in the case of cyanide 
The corresponding logarithmic plot (Fig. 278) supports the"" 
result of direct fitting. The maximal inhibition is 80%. The 
details of data transformation are in Methods. 
The dibucaine effect upon electron transfer was 
investigated by following the steady state spectral change at the 
445-470nm wavelength pair(Fig. 28). Whether the reducing 
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Fig. 27(A). Fast and slow phases of dibucaine inhibition of 103 
cytochrome oxidase 
This experiment was carried out in 50 mM potassium phosphate, 
pH 7.4, 0.0150/0 lauryl maltoside at 30°C with the DW-2 dual 
wavelength spectrophotometer. 7.4 mM ascorbate was added to a 
mixture of 85 nM aa3 and 13 J..lM cyt. c in a 1cm-lightpath. 1ml-
volume quartz cuvette to start the reaction. 1.5 mM dibucaine was 
then added during the steady state as indicated . Measurements 
were made at the 550-540nm wavelength pair. 
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Fig. 27(8) Kinetics of dibucaine inhibition monitored by 104 
the cytochrome c steady state. 
The experimental data are taken from the single set of results in 
Fig. 27(A). The end point (final steady state cytochrome c 
reduction) was estimated using the OlisTM fitting routine for a 
double exponential rise function (see Methods). The changes of 
uninhibited oxidase concentration ([El. closed symbols) with time 
were calculated as described in Methods. The two straight lines 
were drawn by hand to indicate two phases. Conditions are as in 
the legend to Fig.27(A}. 
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Fig. 28A Effect of dibucaine on the steady state of 105 
cytochrome oxidase : ascorbate + TMPD as reductants 
The experiments were conducted in 10mM potassium phosphate, 
pH 7.4, 0.015% lauryl maltoside at 30°C. 4JlM enzyme was 
incubated in 2mM dibucaine for 30min before 10mM ascorbate 
,.plus O.4mM TMPD were added to the enzyme solution to start the 
reaction. Measurements were made at 445-470nm wavelength 
pair. DW-2 dual wavelength spectrophotometer; 1 cm-lightpath, 
1 ml-volume quartz cuvette . 
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Fig. 288 Effect of dibucaine on the steady state of 106 
cytochrome oxidase TMPD plus cytochrome c as 
reductants 
The experiments were conducted in 10mM potassium phosphate, 
pH 7.4, 0.015% lauryl maltoside at 30°C. 4~M enzyme was 
incubated in 2mM dibucaine for 30min before 10mM ascorbate 
plus 40~M TMPD were added to the enzyme-cytochrome c 
mixture to start the reaction. The cytochrome c concentration 
was 5~M. Measurements were made at 445-470nm wavelength 
pair. DW-2 dual wavelength spectrophotometer; 1 cm-lightpath, 
1 ml-volume quartz cuvette . 
equivalents were ascorbate plus TMPD(Fig.28A), or cytochrome c 107 
(Fig.28B), the presence of dibucaine caused a substantial rise of 
steady state reduction at 445-470nm, indicating an increase in 
the steady state amount of reduced cytochrome a which in turn 
suggests an inhibition of electron transfer between cytochrome a 
and the binuclear center . But after anaerobiosis the spectral 
change in the presence of a high concentration of dibucaine(::=2mM) 
was very close to that under control conditions. Adding dithionite 
had only a small additional effect. This indicated that both 
cytochromes a and a3 were fully reduced after anaerobiosis. In 
addition, unlike cyanide and formate (Nicholls and Chanady 1982, 
Nicholls 1976), there was no observable change of the reduction 
rate of a3 monitored at anaeJobiosis. This result is· contrary to 
the claim by Stringer and Harmon(1990) that dibucaine blocked 
the reduction of a 3 completely but is compatible with the 
observation that the maximum ~ercentage of inhibition by 
dibucaine is 80%(Fig. 26B). 
No perturbation of CUA was seen(Fig.29). When ascorbate 
plus TMPD were the reducing equivalents(Fig.29A), CUA was 
partially reduced during the steady state, which was evidenced by 
a decrease of absorbance at 830nm, the absorption band 
attributed to cupric CUA(Nicholls and Chanady 1982} .. The higher 
steady state of cytochrome a and the prolonged anaerobiosis 
time(100 seconds in the presence of dibucaine, compared with 52 
seconds in control conditions) indicated that the electron 
transfer between a and the binuclear center was inhibited. After 
anaerobiosis, both cytochrome a and CUA were fully reduced in the 
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Fig. 29A Effect of dibucaine on the steady states of a and 108 
CUA: TMPD is the reductant 
The experiments were carried out in 50 mM potassium phosphate, 
pH 7.4, 0.015% lauryl maltoside at 30°C. 11 mM ascorbate .and 
0.23 mM TMPD were added to 20).1M resting enzyme or 20).1M 
.resting enzyme previously incubated in 1.0 mM dibucaine for 40 
min. DW-2 dual wavelength spectrophotometer; 1 cm-lightpath, 
1 ml-volume quartz cuvette. 
Absorbance 
1.00 
0.75 
0.50 
0.25 
,'\ 
: I 
I I 
I 
Anaerobiosis 
Steady state 
Resting 
,,~ +dibucaine 
Fig. 29(8) 
, 
, , 
" \\ 
" 1\ 
" \I n 
" 
" \t 
" \\ 
" \\ 
" 
" 
" \\ 
" 
" ". 
". 
". , 
, 
, 
" 
, 
, 
, 
, 
.. 
- - - - Control 
+Dibucaine 
"'-4. --:----- _ 
... ~ ...J"" "'~-",,-.... ,,:-... 
Resting 
+dibucaine ~
,~t. 
, I 
Steady state 
.......... Anaerobiosis .... 
"-' ... ...t ...... , .......... 
..... --::~~~~­
... <1" ....... 
~ .. :::::: .......... ---.... I-,.'_ .. _,~-------~ 
- .... ,,-....... ,.- - ... -- --..-
'" ~-.. -.. --.. -... ,~,....... ~ 
...... _-........ .. 
... 7'--
+Dithionite 
0.01 I , I I I ! 
540 600 660 720 . 780 840 
Wavelength(nm) 
Fig. 29B Effect of dibucaine on the steady states of a and 109 
CUA: cytochrome c is the reductant 
The experiments were carried out in 50 mM potassium phosphate, 
pH 7.4, 0.015% lauryl maltoside at SO°C. 19.4 ~M .cytochrome c· 
was mixed with 20~M resting enzyme or 20 ~M resting enzyme 
.previously incubated in 1.0 mM dibucaine for 40 min. Then, 11 mM 
ascorbate was added to the mixture to start the reaction. DW-2 
dual wavelength spectrophotometer; 1 cm-lightpath, 1 ml-volume 
quartz cuvette. 
presence of dibucaine, and adding dithionite had little further 110 
effect. When cytochrome c was used(Fig.298) , there was little 
spectral change at 830nm during the steady state both in control 
conditions and in the presence of dibucaine, indicating that· CUA 
remained mostly oxidized during a steady state. This phenomenon 
. was observed previously by Nicholls and Chanady (1982). On the 
other hand, dibucaine greatly increased the steady state reduction 
of cytochrome a , indicating a strong inhibition of electron 
transfer between a and the binuclear center. After anaerobiosis, 
CUA was again fully reduced in the presence of dibucaine, adding 
dithionite had little extra effect. 
Based on the above observation, it seems that CUA is not the 
site of dibucaine attack as Stringer and Harmon(1990) suggested. 
All the experiments described so far have involved the 
isolated enzyme,· What about other forms of the enzyme? Is the 
con'clusion drawn from the isolat91d enzyme still valid for . the 
enzyme in its physiological environment? To answer this 
question, the dibucaine effect on cytochrome oxidase in 
submitochondrial particles was tested(Fig. 30). In 
submitochondrial particles, the substrate for the enzyme, 
cytochrome c , is inside the vesicles. Therefore TMPD, a 
membrane-permeable reductant, is· chosen as the source. of 
reducing equivalents. Ascorbate, the agent usually employed to 
keep TMPD reduced, cannot reduce the oxidized TMPD trapped in 
the membrane because it is membrane-impermeable. To solve this 
problem and avoid the absorption interference from oxidized 
TMPD(Wursters blue), the submitochondrial particles were first 
Fig. 30{A) 
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Fig. 30A Effect of dibucaine on the steady state behaviour III 
of submitochondrial particles: 445-470nm 
The experiments were conducted in SOmM potassium phosphate, 
pH 7.4 at 30°C .Submitochondrial particles were incubated in 
24JlM antimycin for 5 min before 2SmM succinate and 3.33mM 
,ascorbate plus 0.1 mM TMPD were added to commence the 
reaction. Dibucaine concentrations varied from 0.0 to 3mM, and 
the incubation time was 30m in. DW-2 dual wavelength 
spectrophotometer; 1 cm-lightpath, 1 ml-volume quartz cuvette. 
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Fig. 308 Effect of dibucaine on the steady state behaviour 112 
of submitochondrial particles: 605-630nm 
The steady state spectral change was monitored at 605-630nm 
instead of 445-470nm, other conditions are identical as those of 
Fig. 30A. 
incubated with 24 J.lM antimycin( an inhibitor of cytochrome b/C1 113 
complex, Cramer and Knaff1991 )to make sure that cytochrome c 
would not be reduced by cytochrome b/C1 complex. An excess 
(25mM) of succinate, a membrane-permeable reducing agent, 
was then added to reduce the membrane bound TMPD. As it turned 
,.:. out, similar to the re·sults with isolated enzyme, dibucaine 
increased the steady state of cytochrome 8 when monitored in 
both the 445-470nm(Fig. 30A) and 604-630nm(Fig. 308) regions, 
suggesting an inhibition of electron transfer between 
cytochrome 8 and the binuclear center. Dibucaine had little 
effect upon the rate of 83 reduction when monitored at 
anaerobiosis nor did it inhibit the reduf;tion of 83. The similarity 
between this result and those of experiments with isolated 
enzyme suggests that dibucaine has a similar effect upon isolated 
enzyme and the enzyme in submitochondrial particles as well . 
Less marked steady state spectral changes in submitochondrial 
particles induced by dibucaine(Fig. 30) , as compared with the 
isolated enzyme(Fig. 28), is probably due to the fact that 
dibucaine can bind other components of the respiratory chain 
within submitochondrial particles as well as the oxidase 
(Chazotte and Vanderkooi 1981). 
The severe scattering effects with submitochondrial 
particles and the low absorption at 830nm(ilEmM830-740nm=1.0, 
Nicholls and Chanady 1982) make it very difficult to monitor the 
CUA steady state with the submitochondrial particles. 
The dibucaine effect on the enzyme kinetics in both high 
and low ionic strength systems was also studied 
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Fig.31 Effect of dibucaine on cytochrome oxidase turnover 114 
at high and low ionic strengths: Polarographic study 
The experiments were carried out in 10mM KHEPES plus 70mM 
K2S04 or 10mM KHEPES plus 4mM K2S04 , pH 7.37,0.015% lauryl 
maltoside at 30°C with a Clark type oxygen electrode(Yellow 
,:, Springs Instruments). 25.6jlM EDT A, 3mM ascorbate, 0.,174mM 
TMPD , 0-1.5mM dibucaine, 51 nM cytochrome oxidase and 
various concentrations of cytochrome c as indicated were added 
sequentially. 
The turnover is calculated from the slope of the oxygen electrode 
traces. The mean turnover is shown with ± 1 standard deviation. 
(n=3 ). 
A. High ionic strength(10mM KHEPES plus 70mM K2S04 ). 
B. Low ionic strength (10mM KHEPES plus 4mM K2S04 ). 
polarographically (fig. 31). To keep buffering constant, 10mM 115 
KHEPES plus 70mM K2S04 or 4mM K2S04 were used instead of the 
potassium phosphate buffer. Fig. 31 reveals that at a higher ionic 
strength , the turnover number of the enzyme increases 
hyperbolically with the cytochrome c concentration, while at a 
lower ionic strength, a biphasic, non-hyperbolic rise is seen. This 
general phenomenon has been explained by supposing that the 
enzyme has two binding sites for cytochrome c (Cooper 1990), 
one a "tight" site , and the other a "loose" site. At low ionic 
strengths, both sites are catalytically functional , while at high 
ionic strengths, only one binding site is catalytically functional . 
Fitting the data from Fig. 31 with· a DQubie Michaelis function in 
the MultifitTM programme, the maximum velocities at the "tight" 
site VmT and the "loose" site VmL can be obtained. Fig.32 shows 
that even at high ionic strength(10mM KHEPES plus 70mM K2S04), 
there is some activity at both binding sites . Perhaps the ionic 
strength employed here was not high enough to eliminate fully 
the biphasicity . Dibucaine has little effect on the VmT in both 
high and low ionic strengths, but it decreases the 
Vm(tot)(=VmT+VmL) substantially. Dibucaine does not affect KmT 
and Km L at either high or low ionic strengths(Fig. 33). So 
apparently dibucaine inhibits the "loose " binding site of the 
enzyme non-competitively , decreasing VmL without affecting the 
kinetics of the "tight " site . 
Uncompetitive, noncompetitive and mixed types of 
inhibition have been suggested for dibucaine-induced inhibition 
(Singer 1982 & 1983, Casanovas et al 1983). Here I report a 
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Fig.32 Dibucaine effect on Vmax values for cytochrome 
oxidase at high and low ionic strengths. 
V max values were obtained by fitting the data in Fig.31 to a 
"Double Michaelis" function using the Multifit™ programme. 
Error bars are not shown (but see Fig. 31). 
Conditions as in Fig.31. 
A. High ionic strength(10mM KHEPES plus 70mM K2S04). 
B. Low ionic strength(10mM KHEPES plus 4mM K2S04). 
116 
noncompetitive inhibition of cytochrome oxidase activity by 11 7 
dibucaine. It may be noted that an apparent uncompetitive 
behaviour could be derived from results under biphasic binding 
conditions where only the second phase is dibucaine-sensitive. 
This may account for the earlier reports of uncompetitive and 
mixed· inhibition patterns. 
The dibucaine-reconstituted cytochrome oxidase interaction 
was also investigated polarographically (Fig. 34). When a low 
concentration« 1 mM) of dibucaine was added to the tightly 
controlled cytochrome oxidase-contained proteoliposomes 
(Fig. 34A) , a stimulation of the respiration rate was seen. The 
,d~bucaine concentration causing halfh maximal stimulation is 
estimated to be 0.2mM. The respiration rate reached a saturating 
level of 70JlM electron equivs. sec- 1 when the dibucaine 
concentration exceeded 1 mM. This can be best explained by the 
~pH-dissipating effect of dibucaine, since dibucaine is a 
membrane - permeable weak base. When the proteoliposomal 
respiration was released by ionophores(FCCP plus valinomycin), 
dibucaine caused a progressive decrease of t~e respiration rate 
with a Kj = 0.4 mM , suggesting that in addition to the ionophore 
effect, dibucaine also had an inhibition effect. The ionophore 
effect of dibucaine is further supported by the decrease of the 
respiratory control ratio in the presence of dibucaine(Fig.34B). 
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Fig. 33 Dibucaine effect on Km values for cytochrome ell 8 
and cytochrome oxidase at high and low ionic strengths. 
Km values were obtained by fitting the data in Fig.31 to a "Double 
Michaelis" function using the MultifitTM programme. Error bars 
are not shown (but see Fig. 31). 
Conditions as in Fig.31. 
A. High ionic strength (10mM KHEPES plus 70mM K2S04). 
B. Low ionic strength (10mM KHEPES plus 4mM K2S04). 
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Fig. 34 The dibucaine effect on the respiration of 119 
reconstituted cytochrome oxidase . 
Sets of experiments were carried out in SOmM potassium 
phosphate, pH 7.37, at 30°C with a Clark type oxygen 
electrode(Yeliow Springs Instruments}. 241lM EDTA, S.4mM 
ascorbate, O.18mM TMPD ,12 nM reconstituted cytochrome 
oxidase, and 241lM cytochrome c were added. Dibucaine was 
present at the indicated concentrations. The respiration rates 
were calculated from the slopes of oxygen electrode traces. The 
average respiration rates are shown ± 1 standard deviation 
(n = 3). The respiratory control ratios were calculated as the 
ratios between the control respiration rate and the respiration 
rate after adding ionophores (1 IlM valinomycin plus O.16JlM 
n igerici n). 
A. Respiration 
concentration. 
rates plotted against 
Open triangles : uncontrolled rate(+ ionophores) 
Closed circles : controlled rate (- ionophores) 
Continuous lines: arbitrary exponential fits. 
dibucaine 
B. Respiratory control ratio plotted as a function of 
dibucaine concentration • 
Closed circles : ratios of rates from Fig. 34A . 
Continuous line : exponential fit assuming the respiratory control 
ratio equals 1 at hign dibucaine concentrations. 
DISCUSSION 
Using spectrophotometric and oxygen electrode techniques, 
the effects of valinomycin and dibucaine upon isolated 
cytochrome c oxidase and cytochrome c oxidase in membrane 
systems.-are·investigated here.-· :It ··is·· found that valinomycin .and 
dibucaine cause a similar but not identical red shift of the Soret 
. peak in the enzyme spectrum. In addition to their inhibitory 
effects on the enzyme activity, valinomycin and dibucaine can 
also act as ionophores in cytochrome oxidase containing vesicle 
systems. 
'" Valinomycin, in the form of its potassium complex,' binds to 
the isolated enzyme in some hydrophobic region of the protein. 
This region may have some anionic character, as valinomycin-K+ 
can form quite specific complexes with ··hydrophobic anions 
including the FCCP anion itself(O'Brien et at 1978). However, the 
dependence on the presence of K+ is more likely due to a 
conformational change of the valinomycin molecule structure 
upon binding with K+ than to a involvement of electrostatic 
forces (Fig. 9). The valinomycin molecule can assume different 
conformations in different media (Ovchinnikov 1974). In non-
polar media, it assumes a compact symmetric structure with the 
six carbonyl oxygen atoms pointing away from the centre; in polar 
media, it assumes a flatter structure with the six carbonyl 
oxygen atoms locating on one plane, forming a triangle(Fig. 3B). 
Upon binding the K+ ion, all the six carbonyl oxygen atoms become 
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liganded to the K+ at the centre , forming an octahedral-like 121 
shape with the oxygen atoms from the peptide bonds pointing 
outwards. Probably these oxygen atoms from the peptide bonds as 
well as the hydrophobic side chains are responsible for binding to 
the enzyme. This site may be located somewhere near the 
. binuclear centre, as Its' -occupancy causes the Soret band red 
shift(an apparent high- to low- spin state change). The effect is 
distinct ·from that induced in 'pulsed' enzyme , and more similar 
to the cyanide-induced change, although of a smaller magnitude 
by about 60%. Like the cyanoenzyme, and unlike the 'pulsed' form, 
the valinomycin-enzyme complex is inhibited. But unlike the 
cyanide complex,· the inhibition is if'lcomplete. This inhibition 
occurs with both isolated and vesicular enzyme(Fig. 10, Fig. 13) 
at a valinomycin concentration in the 'micromolar range. 
Two effects occur at lower valinomycin concentrations(Fig. 
13). These are the stimulation of flux in the absence of other 
ionophores and the stimulation in the presence of nigericin. The 
former may be due to the action of valinomycin as a proton 
carrier(Hodarnau et al 1986). The latter is presumably due to the 
collapse of the controlling membrane potential (Wrigglesworth et 
al. 1990). It is not the same as the effect on the isolated 
oxidase. The stimulation occurs in the nanomolar range and is 
clearly distinguished from the direct and partially inhibitory 
effects (this thesis , Steverding and Kadenbach 1990, Prochaska 
and Wilson 1991). 
The valinomycin-induced conformational change was also 
studied by monitoring the protein fluorescence and 122 
phosphorescence. There are three amino acid residues(Larowicz 
1983) which contribute to luminescence: tryptophan(trp), 
tyrosine(tyr} and phenylalanine(phe). The emission from 
phenylalanine is rarely observed because of its relatively low 
absbrptibn in the usual protein excitation wavelength range. 
Tyrosine luminescence is also less common than that of 
tryptophan, one reason being that energy can be transferred from 
excited tyrosine residues to tryptophan residues. Above 29Snm, 
the absorption is due primarily to tryptophan. So tryptophan can 
be selectively excited at 29Snm-30Snm. As I have shown in Fig. 
14 , valinomycin has some quenchiPfg effect on the enzyme 
fluorescence , supporting the idea of a conformational change 
induced by valinomycin. In addition, the nitrite quenching 
behaviour was also altered in the presence of valinomycin for an 
excitation wavelength of 260nm(Fig. 16). I propose that when the 
excitation wavelength is 290nm, only tryptophan residues are 
excited, valinomycin has little effect. At an excitation 
wavelength of 260nm, some tyrosine residues are also excited. 
Valinomycin causes a conformational change of the protein 
structure that prevents the access to one part of these tyrosine 
residues by the quencher nitrite; this results in a decreased 
overall quenching of the phosphorescence signal(Table 3) . On the 
other hand, the quenching constant KO itself increases in the 
presence of valinomycin , indicating that some residues become 
more accessible to nitrite because of this valinomycin-induced 
conformational change . 
Comparison of the effects of dibucaine upon COV systems 
(Fig. 34) and upon the intact enzyme (Fig. 19 and 26) shows that 
like valinomycin -K+ , there are two different types of dibucaine 
effect. Proteoliposomal activation requires 0.1 to O.SmM 
anaesthetic while inhibition involves O.S to SmM levels. The 
rates are also different. The ionophore-like behaviour is rapid, 
while the enzyme binding is slow, requiring tens of minutes or 
even hours for completion .in the absence of turnover (Fig.20A). 
Inhibition still requires significant times to develop in actively 
turning over system (Fig.27A). Most of my inhibitor studies 
involved preincubation of the enzyme and the inhibitor. Similar 
conclusions can be drawn from the results of Chazotte and 
Vanderkooi (1981) who recognized stimulatory and inhibitory 
concentration ranges. 
Vanderkooi and Chazotte(198!) and Stringer and 'Harm'On 
(1990) , used dibucaine to probe the oxidase mechanism . The 
latter observed blockage of both ascorbate plus TMPD dependent 
cytochrome a3 reduction and of CUA reduction with normal 
cytochrome c depleted beef heart mitochondria . Inhibitors that 
block cytochrome a3 reduction, such as cyanide, promote 
reduction of CUA; and inhibitors of CUA reduction :norrnally have 
no effect upon the binuclear a 3 CUB centre. In the present 
experiments, low concentrations of dibucaine«SmM) were found 
to inhibit the enzyme by interfering with electron transfer 
between cytochrome' a and the binuclear centre. The steady 
states of CUA were little affected by the presence of dibucaine, 
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and the anaerobic transition of the cytochrome a 3 was 
kinetically very similar to the transition in the controls. So the 
attack site of dibucaine apparently is the electron transfer 
between cytochrome a and the binuclear centre , not the CUA 
centre as Stringer and Harmon (1990) suggested. 
That the dibucaine-cytochrome oxidase interaction is 
kinetically reversible has been demonstrated by several authors 
(Vanderkooi and Chazotte 1982, Grouselle et al 1990). Although I 
have not directly examined such reversibility spectroscopically, 
the results described here suggest that, like the kinetic effects, 
the spectroscopic ones are also reversible. On the other hand, 
there is no mention in the literature of the reversibility of 
valinomycin-cytochrome oxidase interaction, but, judged from its 
relatively small maximal effect upon the oxidase activity, and 
from its adherence to the binding equation, presumably this 
process is also a reversible one. Although valinomycin and 
dibucaine cause superficially similar spectral shifts of the 
enzyme to those caused by conventional ligands such as cyanide, 
the interactions are fundamentally different. The differences are: 
(i) both are large amphiphilic molecules which bind the protein 
structure instead of haem groups ; (ii) the changes are less 
marked than with cyanide; (iii) unlike cyanide, only partial 
inhibition is achieved; and, (iv) no dramatic spectral changes are 
seen during steady state reduction in the presence of these 
substances (Fig. 23) while cyanide , azide and formate cause 
marked spectral changes during turnover . 
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ValinomycinK+· and dibucaine-oxidase interactions are 
probably analogous (cf. Steverding and Kadenbach 1990). In both 
cases an amphiphilic monocation interacts with the enzyme in a 
region distinct from the binuclear centre and the cytochrome c 
binding site. Dibucaine does not affect formate binding, which 
occurs equally with free and dibucaine-bound enzyme; formate 
can bind to either resting or 'pulsed' enzyme to give a complex 
almost indistinguishable from the 'high-spin' resting form (Moody 
et al 1991; Schoonover and Palmer 1991). The final valinomycin 
or dibucaine complex has a modified Soret peak and shows 
diminished but not zero activity. The spectral change induced by 
valinomycin is the more marked, but valinomycin is less effective 
in inhibiting the enzyme. These spectral and kinetic effects 
identify an enzyme site which influences electron transfer 
between cytochrome 8 and the cytochrome 83 CUB centre. 
Somewhere between cytochrome 8 and the binuclear centre lies a 
hydrophobic and perhaps anionic site that can bind fairly large 
species so that the resting a 3 CUB spectrum is modified and 
electron transfer slowed (cf. ATP binding, Bisson et al 1987). 
The exact location of this site is difficult to determine from 
currently available knowledge. Subunit III is known to be 
somehow related to proton pumping activity (Brunori et al 1987; 
Prochaska and Fink 1987 ), and it is easy to deplete the enzyme 
of subunit III (Cooper et at 1991). The depleted enzyme shows a 
red-shifted Soret peak (Tihova et al 1992 ). Sone and Nicholls 
(1984) reported that after heating the oxidase to 43.5°C , the 
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enzyme lost H+ -pumping capability without affecting turnover. 126 
These authors could not rule out the possibility of a functional 
dissociation of subunit III. The Soret peak of heated cytochrome 
oxidase was also red shifted. Such red shifts of the Soret peak 
are related to dissociation or damage to subunit III. Dibucaine 
causes a partial dissociation of the F1 complex (Chazotte, et al 
1982). It is thus possible that dibucaine, and perhaps valinomycin 
as well, binds at the interface of Subunits I and III, causing a 
partial dissociation of subunit III from the rest of the enzyme, 
which in turn triggers a conformational change of the whole 
enzyme structure. The major aspects of valinomycin- and 
dibucaine- oxidase interactions are summarized in Table 5, to 
allow comparisons to be made. 
I propose the scheme for valinomycin and dibucaine 
inhibition in Fig. 35, to compare with other inhibitors of 
cytochrome oxidase. Hill(1991) claims that the CUA site is 
probably the first acceptor of electrons entering from 
cytochrome c. Polylysine competes with cytochrome c for the 
binding site on subunit II, thus inhibiting the reduction of CUA by 
cytochrome c . Cyanide , azide and formate are ligands of the 
binuclear centre, so they inhibit entrance of electrons into that 
centre. Carbon monoxide occupies the dioxygen binding site 
(Nicholls and Chance 1974) , thus inhibiting the reoxidation of the 
binuclear centre. Finally, valinomycin and dibucaine cause a 
conformational change of subunit I, diminishing the rate of the 
electron transfer between cytochrome a and the binuclear centre. 
Table 5 
ilEmM Kd lonophore 
Ligand (with resting Inhibition Ki Maximum effect 433-413nm enzyme) concen-
(mM-1 cm -1) ype inhibition ration 
non- I Valinomycir 22 2.5-3.0~M 1.0/-LM 55% < 0.05/-LM 
com petitive 
non-
Dibucaine 9.5 0.65mM 0.7mM 80% O.1-0.5mM 
competitive 
-~-~ '--~ -~-.----~ 
Table. 5 Comparison of valinomycin.. and dibucaine- 127 
cytochrome c oxidase interactions. 
The values listed summarize the results shown in Figs. 7, 11, 21 
and 26. The conditions in each case are listed in the legends to 
these figures. 
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Fig. 35. A scheme for inhibition of electron transport 128 
through cytochrome c oxidase to molecular oxygen. 
CONCLUSIONS 
(1) Valinomycin-K+ complex binds with the isolated cytochrome c 
oxidase with a Kd in the micromolar range, causing a red shift of 
the Soret peak in the enzyme spectrum and a maximal SS% 
Jnhibition of the enzyme activity. 
(2) The membrane potential dissipating ability of valinomycin 
saturates at a much lower .concentration« O.OSJlM) than required 
to cause an inhibition. 
(3) Dibucaine binds with the isolated cytochrome c oxidase with 
a Kd .,. O.SmM, causing a biphasic red shift of the Soret peak and a 
maximal 80% inhibition of the enzyme. activity. 
(4) Dibucaine acts as an ionophore in the concentration range of 
0.1-0.SmM , and it acts as an enzyme inhibitor at the O.SmM to 
til' 
SmM levels. 
(S) 80th valinomycin and dibucaine inhibit cytochrome c oxidase 
non-competitively by causing a conformational change of the 
protein structure which modifies the spectrum of the 83 C u 8 
centre and diminishes the rate of electron transfer between 
cytochrome 8 and the binuclear centre. 
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